| Year |
Citation |
Score |
| 2023 |
Reese SW, Eismann L, White C, Villada JA, Khaleel S, Ostrovnaya I, Vazquez-Rivera K, Carlo MI, Feldman D, Lee CH, Motzer R, Voss MH, Kotecha RR, Matulewicz RS, Goh A, ... ... Russo P, et al. Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma. Urologic Oncology. PMID 38135627 DOI: 10.1016/j.urolonc.2023.12.003 |
0.341 |
|
| 2023 |
Blum KA, Silagy AW, Knezevic A, Weng S, Wang A, Mano R, Marcon J, DiNatale RG, Sanchez A, Tickoo S, Gupta S, Motzer R, Haas NB, Kim SE, Uzzo RG, ... ... Russo P, et al. Localized Non-Metastatic Sarcomatoid Renal Cell Carcinoma: A 31 Year Externally Verified Study. Bju International. PMID 37589200 DOI: 10.1111/bju.16125 |
0.318 |
|
| 2023 |
Hahn AW, Kotecha RR, Viscuse PV, Pieretti AC, Wiele AJ, Jonasch E, Lee CH, Gao J, Zurita AJ, Shah AY, Campbell MT, Sharma P, Motzer RJ, Russo P, Wood CG, et al. Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy. European Urology Focus. PMID 36863962 DOI: 10.1016/j.euf.2023.02.008 |
0.336 |
|
| 2023 |
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, et al. Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial. Lancet (London, England). PMID 36774933 DOI: 10.1016/S0140-6736(22)02574-0 |
0.302 |
|
| 2022 |
Golkaram M, Kuo F, Gupta S, Carlo MI, Salmans ML, Vijayaraghavan R, Tang C, Makarov V, Rappold P, Blum KA, Zhao C, Mehio R, Zhang S, Godsey J, Pawlowski T, ... ... Russo P, et al. Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape. Genome Medicine. 14: 143. PMID 36536472 DOI: 10.1186/s13073-022-01146-3 |
0.343 |
|
| 2022 |
Tourigny DS, Zucker M, Kim M, Russo P, Coleman J, Lee CH, Carlo MI, Chen YB, Hakimi AA, Kotecha RR, Reznik E. Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma. Frontiers in Oncology. 12: 910147. PMID 35837094 DOI: 10.3389/fonc.2022.910147 |
0.345 |
|
| 2022 |
Silagy AW, Tin AL, Rappold P, Vertosick EA, Mano R, Attalla K, Yoo A, Weng S, DiNatale RG, Vickers AJ, Sjoberg DD, Coleman JA, Russo P, Hakimi AA. Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma. Clinical Genitourinary Cancer. PMID 35753989 DOI: 10.1016/j.clgc.2022.05.010 |
0.341 |
|
| 2022 |
Yoo A, Tang C, Zucker M, Fitzgerald K, DiNatale RG, Rappold PM, Weiss K, Freeman B, Lee CH, Schultz N, Motzer R, Russo P, Coleman J, Reuter VE, Chen YB, et al. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas. European Urology Focus. PMID 35288096 DOI: 10.1016/j.euf.2021.12.002 |
0.346 |
|
| 2022 |
Carlo MI, Attalla K, Mazaheri Y, Gupta S, Yildirim O, Murray SJ, Coskey DT, Kotecha R, Lee CH, Feldman DR, Russo P, Patil S, Motzer RJ, Coleman JA, Durack JC, et al. Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy. European Urology. PMID 35183395 DOI: 10.1016/j.eururo.2022.01.043 |
0.322 |
|
| 2021 |
Truong H, Sheikh R, Kotecha R, Kemel Y, Reisz PA, Lenis AT, Mehta NN, Khurram A, Joseph V, Mandelker D, Latham A, Ceyhan-Birsoy O, Ladanyi M, Shah NJ, Walsh MF, ... ... Russo P, et al. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing. European Urology Oncology. PMID 34654685 DOI: 10.1016/j.euo.2021.09.005 |
0.33 |
|
| 2021 |
Mano R, Duzgol C, Ganat M, Goldman DA, Blum KA, Silagy AW, Walasek A, Sanchez A, DiNatale RG, Marcon J, Kashan M, Becerra MF, Benfante NE, Coleman JA, Kattan MW, ... Russo P, et al. Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. Urologic Oncology. PMID 34580025 DOI: 10.1016/j.urolonc.2021.08.018 |
0.338 |
|
| 2021 |
Alvim RG, Tin AL, Nogueira L, Wong NC, Fonseca RC, Sjoberg DD, Hakimi AA, Touijer KA, Russo P, Coleman JA. Functional and oncological outcomes of renal surgery for hilar tumors: informing the decisions in risk-adapted management. Urology. PMID 34331997 DOI: 10.1016/j.urology.2021.07.014 |
0.38 |
|
| 2021 |
Silagy AW, Kotecha RR, Weng S, Holmes A, Singla N, Mano R, Attalla K, Weiss KL, DiNatale RG, Patil S, Coleman JA, Motzer RJ, Russo P, Voss MH, Hakimi AA. Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma. Cancer. PMID 34286865 DOI: 10.1002/cncr.33790 |
0.387 |
|
| 2021 |
Attalla K, DiNatale RG, Rappold PM, Fong CJ, Sanchez-Vega F, Silagy AW, Weng S, Coleman J, Lee CH, Carlo MI, Durack JC, Solomon SB, Reuter V, Russo P, Chan TA, et al. Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34261695 DOI: 10.1158/1078-0432.CCR-20-4058 |
0.324 |
|
| 2021 |
Mano R, Tin AL, Silagy AW, Haywood SC, Huang C, Benfante N, Fischer GW, Vickers AJ, Russo P, Coleman JA, McCormick PJ, Mincer JS, Hakimi AA. The association between modifiable perioperative parameters and renal function after nephrectomy. Bju International. PMID 34196093 DOI: 10.1111/bju.15531 |
0.304 |
|
| 2021 |
Singla N, Huang C, Benfante NE, Wong NC, Hakimi AA, Russo P. Open partial nephrectomy with kidney split: Effective surgical approach to resect completely endophytic tumors. Urologic Oncology. PMID 33853747 DOI: 10.1016/j.urolonc.2021.02.021 |
0.357 |
|
| 2021 |
Alvim R, Tin A, Nogueira L, Lebdai S, Wong N, Takeda T, Assel M, Hakimi AA, Touijer K, Russo P, Coleman J. A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 47: 777-783. PMID 33848068 DOI: 10.1590/S1677-5538.IBJU.2020.0149 |
0.372 |
|
| 2021 |
Silagy AW, Attalla K, Dinatale RG, Weiss KL, Weng S, Mano R, Iosepovici S, Marcon J, Reznik E, Kotecha RR, Motzer RJ, Voss MH, Coleman JA, Hakimi AA, Russo P. A qualitative framework of non-selection factors for cytoreductive nephrectomy. World Journal of Urology. PMID 33779820 DOI: 10.1007/s00345-021-03650-4 |
0.331 |
|
| 2021 |
Gleeson JP, Nikolovski I, DiNatale RG, Zucker M, Knezevic A, Patil S, Ged Y, Kotecha RR, Shapnik N, Murray S, Russo P, Coleman J, Lee CH, Stadler ZK, Hakimi AA, et al. Comprehensive Molecular Characterization and Response to Therapy in FH-Deficient Renal Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33658299 DOI: 10.1158/1078-0432.CCR-20-4367 |
0.344 |
|
| 2021 |
Attalla K, Duzgol C, McLaughlin L, Flynn J, Ostrovnaya I, Russo P, Bilsky MH, Hakimi AA, Moss NS. The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination. Urologic Oncology. PMID 33423935 DOI: 10.1016/j.urolonc.2020.12.008 |
0.305 |
|
| 2021 |
Marcon J, Di Natale R, Weng S, Ghanaat M, Silagy A, Mano R, Blum K, Attalla K, Reznik E, Carlo M, Motzer R, Coleman J, Russo P, Hakimi A, Chen Y. Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups European Urology. 79: S839-S840. DOI: 10.1016/s0302-2838(21)00990-8 |
0.318 |
|
| 2020 |
Blum KA, Gupta S, Tickoo SK, Chan TA, Russo P, Motzer RJ, Karam JA, Hakimi AA. Sarcomatoid renal cell carcinoma: biology, natural history and management. Nature Reviews. Urology. PMID 33051619 DOI: 10.1038/s41585-020-00382-9 |
0.342 |
|
| 2020 |
Weng S, DiNatale RG, Silagy A, Mano R, Attalla K, Kashani M, Weiss K, Benfante NE, Winer AG, Coleman JA, Reuter VE, Russo P, Reznik E, Tickoo SK, Hakimi AA. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management. European Urology. PMID 33046271 DOI: 10.1016/j.eururo.2020.09.027 |
0.364 |
|
| 2020 |
Mano R, Duzgol C, Ganat M, Goldman DA, Blum KA, Silagy AW, Walasek A, Sanchez A, DiNatale RG, Marcon J, Kashan M, Becerra MF, Benfante N, Coleman JA, Kattan MW, ... Russo P, et al. Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. Urologic Oncology. PMID 32900625 DOI: 10.1016/J.Urolonc.2020.07.019 |
0.344 |
|
| 2020 |
Silagy AW, Hannum ML, Mano R, Attalla K, Scarpa JR, DiNatale RG, Marcon J, Coleman JA, Russo P, Tan KS, Fischer GW, McCormick PJ, Ari Hakimi A, Mincer JS. Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia. British Journal of Anaesthesia. PMID 32703551 DOI: 10.1016/j.bja.2020.06.036 |
0.302 |
|
| 2020 |
Silagy AW, Duzgol C, Marcon J, DiNatale RG, Mano R, Blum KA, Reznik E, Voss MH, Motzer RJ, Coleman JA, Russo P, Akin O, Hakimi AA. An evaluation of the role of tumor load in cytoreductive nephrectomy. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 32569570 DOI: 10.5489/Cuaj.6350 |
0.337 |
|
| 2020 |
Hötker AM, Karlo CA, Di Paolo PL, Zheng J, Moskowitz CS, Russo P, Hricak H, Akin O. Renal cell carcinoma: Associations between tumor imaging features and epidemiological risk factors. European Journal of Radiology. 129: 109096. PMID 32559590 DOI: 10.1016/J.Ejrad.2020.109096 |
0.334 |
|
| 2020 |
Brant A, Almassi N, Sirintrapun SJ, Russo P. Upper tract urothelial carcinoma in a patient with horseshoe kidney. Urology. PMID 32389816 DOI: 10.1016/j.urology.2020.04.097 |
0.333 |
|
| 2020 |
Russo P. Historical perspective on partial nephrectomy and renal functional preservation. Urology. PMID 32311444 DOI: 10.1016/j.urology.2020.04.044 |
0.324 |
|
| 2020 |
Marcon J, DiNatale RG, Sanchez A, Kotecha RR, Gupta S, Kuo F, Makarov V, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Benfante NE, Ortiz MV, Carlo MI, ... ... Russo P, et al. Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32220885 DOI: 10.1158/1078-0432.Ccr-19-3283 |
0.362 |
|
| 2020 |
Attalla K, Duzgol C, McLaughlin L, Flynn J, Ostrovnaya I, DiNatale RG, Silagy AW, Coleman J, Lee C, Carlo MI, Voss MH, Russo P, Bilsky M, Hakimi AA, Moss N. The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination. Journal of Clinical Oncology. 38: 742-742. DOI: 10.1200/Jco.2020.38.6_Suppl.742 |
0.302 |
|
| 2020 |
Picola Brau N, Rivero Belenchón I, Mercader Barrull C, Benfante N, Vigués Julià F, Apatov S, Russo P, Coleman J, Touijer K. Multiple partial nephrectomy for multifocal synchronous renal cancer in a solitary kidney European Urology Open Science. 19: e2398. DOI: 10.1016/s2666-1683(20)34253-1 |
0.332 |
|
| 2020 |
Marcon J, Duzgol C, Kuo F, Weiss K, Di Natale R, Mano R, Silagy A, Blum K, Weng S, Attalla K, Reznik E, Coleman J, Russo P, Ahmed F, Akin O, et al. Transcriptomic correlates of non-enhancing tumor volume on imaging in clear cell renal cell carcinoma European Urology Open Science. 19: e1486-e1487. DOI: 10.1016/s2666-1683(20)33584-9 |
0.347 |
|
| 2019 |
DiNatale RG, Gorelick AN, Makarov V, Blum KA, Silagy AW, Freeman B, Chowell D, Marcon J, Mano R, Sanchez A, Attalla K, Weng S, Voss M, Motzer RJ, Russo P, et al. Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course. European Urology Focus. PMID 31813809 DOI: 10.1016/J.Euf.2019.11.013 |
0.336 |
|
| 2019 |
DiNatale RG, Xie W, Becerra MF, Silagy AW, Attalla K, Sanchez A, Mano R, Marcon J, Blum KA, Benfante NE, Voss MH, Motzer RJ, Coleman J, Choueiri TK, Reznik E, ... Russo P, et al. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy. European Urology Oncology. PMID 31735646 DOI: 10.1016/J.Euo.2019.10.002 |
0.394 |
|
| 2019 |
Silagy AW, Mano R, Blum KA, DiNatale RG, Marcon J, TIckoo SK, Reznik E, Coleman JA, Russo P, Hakimi AA. The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-year Institutional Experience. Urology. PMID 31726184 DOI: 10.1016/j.urology.2019.08.058 |
0.394 |
|
| 2019 |
Basourakos SP, Dean L, Van Gurp J, Reuter V, Russo P. Pheochromocytoma arising in the settingof adrenal-renal fusion. The Canadian Journal of Urology. 26: 9952-9955. PMID 31629446 |
0.356 |
|
| 2019 |
Shantharam G, Huang C, Singla N, Chen YB, Russo P. Primary Renal Well-Differentiated Neuroendocrine Tumor Extending into the Inferior Vena Cava. Urology. PMID 31593703 DOI: 10.1016/j.urology.2019.09.031 |
0.318 |
|
| 2019 |
Mano R, Flynn J, Blum KA, Silagy AW, DiNatale RG, Marcon J, Wang A, Sanchez A, Coleman JA, Russo P, Ostrovnaya I, Hakimi AA. The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma. Urologic Oncology. PMID 31590969 DOI: 10.1016/J.Urolonc.2019.09.006 |
0.336 |
|
| 2019 |
Silagy AW, Flynn J, Mano R, Blum KA, Marcon J, DiNatale RG, Sanchez A, Carlo MI, Motzer RJ, Coleman JA, Russo P, Ostrovnaya I, Chen YB, Ari Hakimi A. Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma. Urologic Oncology. PMID 31521530 DOI: 10.1016/J.Urolonc.2019.07.011 |
0.375 |
|
| 2019 |
Vilaseca A, Guglielmetti G, Vertosick EA, Sjoberg DD, Grasso A, Benfante NE, Nguyen DP, Corradi RB, Coleman J, Russo P, Vickers AJ, Touijer KA. Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity. European Urology Oncology. PMID 31411969 DOI: 10.1016/j.euo.2019.04.003 |
0.33 |
|
| 2019 |
Casuscelli J, Becerra MF, Seier K, Manley BJ, Benfante N, Redzematovic A, Stief CG, Hsieh JJ, Tickoo SK, Reuter VE, Coleman JA, Russo P, Ostrovnaya I, Hakimi AA. Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series. Clinical Genitourinary Cancer. PMID 31326335 DOI: 10.1016/J.Clgc.2019.06.011 |
0.402 |
|
| 2019 |
González J, Gaynor JJ, Martínez-Salamanca JI, Capitanio U, Tilki D, Carballido JA, Chantada V, Daneshmand S, Evans CP, Gasch C, Gontero P, Haferkamp A, Huang WC, Espinós EL, Master VA, ... ... Russo P, et al. Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 31155470 DOI: 10.1016/J.Ejso.2019.05.009 |
0.346 |
|
| 2019 |
Ged Y, Chen YB, Knezevic A, Donoghue MTA, Carlo MI, Lee CH, Feldman DR, Patil S, Hakimi AA, Russo P, Voss MH, Motzer RJ. Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes. Clinical Genitourinary Cancer. PMID 31151928 DOI: 10.1016/J.Clgc.2019.04.006 |
0.304 |
|
| 2019 |
Ged Y, Chen YB, Knezevic A, Casuscelli J, Redzematovic A, DiNatale RG, Carlo MI, Lee CH, Feldman DR, Patil S, Hakimi AA, Russo P, Motzer RJ, Voss MH. Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes. Clinical Genitourinary Cancer. PMID 31036466 DOI: 10.1016/J.Clgc.2019.03.018 |
0.349 |
|
| 2019 |
Russo P. A well organised effort to metastatic non-clear-cell renal cell carcinoma. The Lancet. Oncology. PMID 30827747 DOI: 10.1016/S1470-2045(19)30036-1 |
0.363 |
|
| 2019 |
Zareba P, Russo P. The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinoma. Urologic Oncology. PMID 30826169 DOI: 10.1016/j.urolonc.2019.02.006 |
0.308 |
|
| 2019 |
Blum K, DiNatale R, Sanchez A, Silagy A, Marcon J, Mano R, Gupta S, Tickoo S, Reuter V, Coleman J, Russo P, Hakimi AA. Mp42-14 Sarcomatoid Features In Renal Cell Carcinoma: Rethinking The Stage-Survival Paradigm The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556217.19668.90 |
0.356 |
|
| 2019 |
DiNatale R, Lee C, Chowell D, Makarov V, Redzematovic A, Murray S, Carlo M, Voss M, Coleman J, Russo P, Motzer R, Chan T, Hakimi A. Mp25-10 Genomic Biomarkers Of Response To Nivolumab/Ipilimumab And Nivolumab Monotherapy In 108 Patients With Metastatic Renal Cell Carcinoma The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555655.66085.F9 |
0.377 |
|
| 2019 |
Marcon* J, Di Natale RG, Ghanaat M, Silagy AW, Mano R, Blum KA, Reznik E, Carlo MI, Motzer RJ, Coleman JA, Russo P, Hakimi AA, Chen Y. MP21-04 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH PROGNOSIS AND VARIES BETWEEN MOLECULAR SUBGROUPS Journal of Urology. 201. DOI: 10.1097/01.JU.0000555532.02623.55 |
0.356 |
|
| 2019 |
Sanchez* A, Kuo F, Petruzella S, Akin O, Paris M, Russo P, Chan T, Mourtzakis M, Hakimi A, Furberg H. MP16-19 MECHANISMS UNDERLYING THE ASSOCIATION BETWEEN SARCOPENIA AND POOR ONCOLOGIC OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 201. DOI: 10.1097/01.JU.0000555355.36676.05 |
0.341 |
|
| 2019 |
DiNatale* R, Jayakumaran G, Ghanaat M, Marcon J, Brannon R, Al-Ahmadie H, Fine S, Gopalan A, Sirintrapun J, Tickoo S, Arcila M, Motzer R, Coleman J, Russo P, Chan T, et al. MP16-18 MOLECULAR STRATIFICATION OF HIGH-GRADE UNCLASSIFIED RENAL CELL CARCINOMA TO IMPROVE PROGNOSTICATION AND MANAGEMENT Journal of Urology. 201. DOI: 10.1097/01.JU.0000555354.29053.8c |
0.341 |
|
| 2019 |
Marcon J, Sanchez A, Gupta S, Natale RGD, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Motzer RJ, Coleman JA, Russo P, Reuter VE, Hakimi AA, Reznik E. Mp16-15 Comprehensive Analysis Of Oncogenic Events In Translocation Renal Cell Carcinoma The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555351.44300.3F |
0.36 |
|
| 2019 |
Marcon J, Jayakumaran G, Di Natale R, Ghanaat M, Brannon R, Al-Ahmadie H, Fine S, Gopalan A, Sirinitrapun S, Tickoo S, Arcila M, Motzer R, Coleman J, Russo P, Reuter V, et al. Genomic categorization of high-grade unclassified renal cell carcinoma to refine prognostication and therapeutic approach European Urology Supplements. 18: e94-e95. DOI: 10.1016/S1569-9056(19)30071-5 |
0.335 |
|
| 2019 |
Marcon J, Sanchez A, Gupta S, Di Natale R, Sandhu A, Mano R, Silagy A, Blum K, Nassau D, Motzer R, Coleman J, Russo P, Reuter V, Hakimi A, Reznik E. Comprehensive investigation of the molecular underpinnings of translocation renal cell carcinoma European Urology Supplements. 18: e78-e79. DOI: 10.1016/S1569-9056(19)30060-0 |
0.366 |
|
| 2018 |
Zareba P, Pinthus JH, Russo P. The contemporary role of lymph node dissection in the management of renal cell carcinoma. Therapeutic Advances in Urology. 10: 335-342. PMID 30344645 DOI: 10.1177/1756287218794094 |
0.305 |
|
| 2018 |
Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun M, Wood C, Russo P. Epidemiology of Renal Cell Carcinoma. European Urology. PMID 30243799 DOI: 10.1016/j.eururo.2018.08.036 |
0.377 |
|
| 2018 |
Mendonca SJ, Sanchez A, Blum KA, Ghanaat M, Kashan MY, Benfante N, Russo P, Coleman JA, Crago AM, Hakimi AA. The association of renal cell carcinoma with gastrointestinal stromal tumors. Journal of Surgical Oncology. PMID 29878354 DOI: 10.1002/jso.25080 |
0.389 |
|
| 2018 |
Marzouk K, Tin A, Liu N, Sjoberg D, Hakimi AA, Russo P, Coleman J. The natural history of large renal masses followed on observation. Urologic Oncology. PMID 29853347 DOI: 10.1016/j.urolonc.2018.05.002 |
0.318 |
|
| 2018 |
Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra M, Manley BJ, Casuscelli J, Chiok M, Coleman JA, Russo P, Tickoo SK, Akin O, et al. Cystic renal cell carcinoma: a report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging. The Journal of Urology. PMID 29496470 DOI: 10.1016/j.juro.2018.02.3087 |
0.352 |
|
| 2018 |
Blum KA, DiNatale R, Sanchez A, John NT, Axler E, Ghanaat M, Kashan M, Becerra M, Russo P, Coleman J, Tickoo S, Hakimi AA. Sarcomatoid renal cell carcinoma: Does stage impact survival? Journal of Clinical Oncology. 36: 693-693. DOI: 10.1200/JCO.2018.36.6_SUPPL.693 |
0.304 |
|
| 2018 |
Bex A, Grünwald V, Russo P, Tomita Y, Berghorn E, McHenry M, Motzer R. A phase III, randomized, placebo-controlled trial of adjuvant nivolumab plus ipilimumab in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after radical or partial nephrectomy (CheckMate 914) Annals of Oncology. 29: viii330. DOI: 10.1093/ANNONC/MDY283.136 |
0.31 |
|
| 2018 |
Nassau DE, Sanchez A, Dinatale R, Blum KA, Ghanaat M, Gupta S, Arcila ME, Voss MH, Motzer RJ, Russo P, Coleman J, Reznik E, Reuter V, Hakimi AA. MP28-08 CLINICOPATHOLOGIC AND GENOMIC EVALUATION OF TRANSLOCATION RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.908 |
0.335 |
|
| 2018 |
Sanchez A, Petruzella S, Samson M, Akin O, Paris M, Kuo F, Hakimi AA, Russo P, Mourtzakis M, Dannenberg AJ, Furberg H. MP72-17 THE ASSOCIATION BETWEEN SARCOPENIA AND MOLECULAR SUBTYPES OF CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/j.juro.2018.02.2301 |
0.349 |
|
| 2017 |
Winer AG, Zabor EC, Vacchio MJ, Hakimi AA, Russo P, Coleman JA, Jaimes EA. The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy. Clinical Genitourinary Cancer. PMID 29325738 DOI: 10.1016/j.clgc.2017.11.006 |
0.343 |
|
| 2017 |
Lee BH, Zabor EC, Tennenbaum D, Furberg H, Benfante N, Coleman JA, Jaimes EA, Russo P. Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma. World Journal of Urology. PMID 29209771 DOI: 10.1007/s00345-017-2139-9 |
0.341 |
|
| 2017 |
Russo P. Potential new strategies for the treatment of renal medullary carcinoma. Bju International. 120: 744. PMID 29168338 DOI: 10.1111/bju.13758 |
0.326 |
|
| 2017 |
Manley BJ, Reznik E, Ghanaat M, Kashan M, Becerra MF, Casuscelli J, Tennenbaum D, Redzematovic A, Carlo MI, Sato Y, Arcila M, Voss MH, Feldman DR, Motzer RJ, Russo P, et al. Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations. Urologic Oncology. PMID 29132830 DOI: 10.1016/J.Urolonc.2017.10.012 |
0.382 |
|
| 2017 |
Tilki D, Chandrasekar T, Capitanio U, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Lorentz A, Martinez-Salamanca JI, Master VA, McKiernan JM, ... ... Russo P, et al. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Urologic Oncology. PMID 29129353 DOI: 10.1016/J.Urolonc.2017.10.008 |
0.331 |
|
| 2017 |
Zabor EC, Furberg H, Lee B, Campbell S, Lane BR, Thompson RH, Antonio EC, Noyes SL, Zaid H, Jaimes EA, Russo P. Long-term renal functional recovery following radical nephrectomy for kidney cancer: Results from a multi-center confirmatory study. The Journal of Urology. PMID 29066363 DOI: 10.1016/j.juro.2017.10.027 |
0.362 |
|
| 2017 |
Becerra MF, Reznik E, Redzematovic A, Tennenbaum DM, Kashan M, Ghanaat M, Casuscelli J, Manley B, Jonsson P, DiNatale RG, Blum KA, Durack JC, Solomon SB, Arcila ME, Bourque C, ... ... Russo P, et al. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. European Urology Focus. PMID 29066084 DOI: 10.1016/J.Euf.2017.09.016 |
0.381 |
|
| 2017 |
Spaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, Wren J, Russo P, Coleman JA. Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial. European Urology. PMID 28822586 DOI: 10.1016/j.eururo.2017.07.038 |
0.309 |
|
| 2017 |
Rosenzweig B, Rubinstein ND, Reznik E, Shingarev R, Juluru K, Akin O, Hsieh JJ, Jaimes EA, Russo P, Susztak K, Coleman JA, Hakimi AA. Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients. Plos One. 12: e0180350. PMID 28727768 DOI: 10.1371/Journal.Pone.0180350 |
0.399 |
|
| 2017 |
Bjurlin MA, Elkin EB, Atoria CL, Russo P, Taneja SS, Huang WC. Influence of renal biopsy results on the management of small kidney cancers in older patients: Results from a population-based cohort. Urologic Oncology. PMID 28716561 DOI: 10.1016/J.Urolonc.2017.05.025 |
0.316 |
|
| 2017 |
Bertolo RG, Zargar H, Autorino R, Fiori C, Kaouk JH, Russo P, Thompson RH, Porpiglia F. Estimated glomerular filtration rate, renal scan and volumetric assessment of the kidney before and after partial nephrectomy: a review of the current literature. Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology. PMID 28651424 DOI: 10.23736/S0393-2249.17.02865-X |
0.336 |
|
| 2017 |
Sinha R, Winer AG, Chevinsky M, Jakubowski C, Chen YB, Dong Y, Tickoo SK, Reuter VE, Russo P, Coleman JA, Sander C, Hsieh JJ, Hakimi AA. Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection. Nature Communications. 8: 15165. PMID 28489074 DOI: 10.1038/Ncomms15165 |
0.306 |
|
| 2017 |
Tennenbaum DM, Manley BJ, Zabor E, Becerra MF, Carlo MI, Casuscelli J, Redzematovic A, Khan N, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Benfante NE, Coleman JA, Russo P, et al. Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Urologic Oncology. PMID 28408295 DOI: 10.1016/J.Urolonc.2017.03.015 |
0.368 |
|
| 2017 |
Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A, Weinhold N, Lee W, Manley BJ, Khalil DN, Kaffenberger SD, ... ... Russo P, et al. Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biology. 18: 46. PMID 28249590 DOI: 10.1186/S13059-017-1180-8 |
0.319 |
|
| 2017 |
Kopp RP, Stratton KL, Glogowski E, Schrader KA, Rau-Murthy R, Russo P, Coleman JA, Offit K. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Cancer. PMID 28171700 DOI: 10.1002/cncr.30605 |
0.357 |
|
| 2017 |
Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, Gill I, Graham D, Huang W, Jewett MA, Latcha S, Lowrance W, Rosner M, Shayegan B, Thompson HR, ... ... Russo P, et al. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016699645. PMID 28095147 DOI: 10.1200/JCO.2016.69.9645 |
0.303 |
|
| 2017 |
Hötker AM, Mazaheri Y, Wibmer A, Karlo CA, Zheng J, Moskowitz CS, Tickoo SK, Russo P, Hricak H, Akin O. Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach. Ajr. American Journal of Roentgenology. W1-W7. PMID 28095036 DOI: 10.2214/Ajr.16.16652 |
0.383 |
|
| 2017 |
Rosenzweig B, Rubinstein ND, Reznik E, Zareba P, Shingarev R, Juluru K, Akin O, Hsieh J, Jaimes EA, Russo P, Susztak K, Coleman J, Hakimi AA. Effect of benign and tumor parenchyma metabolomic profiles on compensatory renal growth in renal cell carcinoma surgical patients. Journal of Clinical Oncology. 35: 446-446. DOI: 10.1200/Jco.2017.35.6_Suppl.446 |
0.307 |
|
| 2017 |
Lorentz C, Tai C, Capitanio U, Carballido J, Ciancio G, Daneshmand S, Evans C, Gontero P, Haferkamp A, Hohenfellner M, Huang W, Espinós E, Martínez-Salamanca J, McKiernan J, Montorsi F, ... ... Russo P, et al. External validation of the Mayo Clinic Stage, Size, Grade, and Necrosis score in patients with renal cell carcinoma and venous tumor thrombus European Urology Supplements. 16: e1109-e1112. DOI: 10.1016/S1569-9056(17)30697-8 |
0.36 |
|
| 2017 |
Spaliviero M, Power N, Murray K, Sjoberg D, Benfante N, Bernstein M, Wren J, Russo P, Coleman J. Phase 3 randomized trial of intravenous mannitol versus placebo prior to renal ischemia during partial nephrectomy: Impact on renal functional outcomes European Urology Supplements. 16: e369-e370. DOI: 10.1016/S1569-9056(17)30279-8 |
0.303 |
|
| 2017 |
Rosenzweig B, Rubinstein ND, Reznik E, Zareba P, Shingarev R, Juluru K, Akin O, Hsieh JJ, Jaimes E, Russo P, Susztak K, Coleman JA, Hakimi AA. MP73-17 BENIGN AND TUMOR PARENCHYMA METABOLOMIC PROFILES AFFECT COMPENSATORY RENAL GROWTH IN RENAL CELL CARCINOMA SURGICAL PATIENTS Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3362 |
0.407 |
|
| 2017 |
Lorentz A, Tai C, Capitanio U, Carballido J, Ciancio G, Daneshmand S, Evans C, Gontero P, Haferkamp A, Hohenfellner M, Huang W, Linares Espinós E, Martínez-Salamanca J, McKiernan J, Montorsi F, ... ... Russo P, et al. PD04-10 EXTERNAL VALIDATION OF THE MAYO CLINIC STAGE, SIZE, GRADE, AND NECROSIS SCORE IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.229 |
0.317 |
|
| 2017 |
Mendonca S, Ghanaat M, Kashan M, Becerra M, Manley B, Benfante N, Russo P, Coleman J, Crago A, Hakimi AA. MP67-14 CHARACTERIZATION OF RENAL CELL CARCINOMA IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS COMPARED TO OTHER SOFT TISSUE SARCOMAS Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.2050 |
0.36 |
|
| 2017 |
Kashan M, Ghanaat M, Becerra M, Hötker AM, Chiok M, Manley B, Benfante N, Casuscelli J, Mendonca S, Tickoo S, Akin O, Russo P, Coleman J, Hakimi AA. MP55-08 DIAGNOSIS, MANAGEMENT, AND CLINICAL OUTCOMES OF CYSTIC RENAL CELL CARCINOMA Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.1701 |
0.324 |
|
| 2017 |
Zattoni F, Thompson R, Capitano U, Crestani A, Ficarra V, Kutikov A, Larcher A, Lane B, Leibovich B, McIntosh A, Montorsi F, Moon D, Muilwijk T, Murray K, Noyes S, ... Russo P, et al. Partial nephrectomy in the treatment of renal tumors with concomitant venous tumor thrombosis (VTT) of renal vein branches: Retrospective, multi-center analysis of perioperative, functional, and oncologic outcomes European Urology Supplements. 16: e1832-e1833. DOI: 10.1016/J.Juro.2017.02.1698 |
0.349 |
|
| 2017 |
Zattoni F, Thompson RH, Capitanio U, Crestani A, Ficarra V, Kutikov A, Larcher A, Lane BR, Leibovich BC, McIntosh A, Montorsi F, Moon D, Muilwijk T, Murray K, Noyes S, ... Russo P, et al. MP55-05 PARTIAL NEPHRECTOMY IN THE TREATMENT OF RENAL TUMORS WITH CONCOMITANT VENOUS TUMOR THROMBOSIS (VTT) OF RENAL VEIN BRANCHES: RETROSPECTIVE, MULTI-CENTER ANALYSIS OF PERIOPERATIVE, FUNCTIONAL, AND ONCOLOGIC OUTCOMES Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.1698 |
0.35 |
|
| 2017 |
Spaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, Wren JD, Russo P, Coleman JA. MP49-01 PHASE 3 RANDOMISED TRIAL OF INTRAVENOUS MANNITOL VERSUS PLACEBO PRIOR TO RENAL ISCHEMIA DURING NEPHRON-SPARING SURGERY: IMPACT ON RENAL FUNCTIONAL OUTCOMES Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.1503 |
0.304 |
|
| 2017 |
Ghanaat M, Kashan M, Becerra M, Manley B, Casuscelli J, Mendonca S, Redzematovic A, Arcila M, Russo P, Coleman J, Hsieh J, Chen Y, Hakimi AA. MP39-04 MOLECULAR AND CLINICAL CHARACTERIZATION OF RENAL CELL CARCINOMA WITH UNCLASSIFIED HISTOLOGY:
NF2
LOSS PREDICTS WORST OUTCOMES Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1178 |
0.309 |
|
| 2017 |
Becerra M, Sanchez-Vega F, Reznik E, Manley B, Kashan M, Ghanaat M, Casuscelli J, Redzematovic A, Mendonca S, Arcila M, Coleman J, Russo P, Hsieh J, Hakimi AA. MP39-03 IMPACT OF SOMATIC MUTATIONS ON PATTERNS OF METASTASIS IN CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1177 |
0.322 |
|
| 2017 |
Becerra M, Reznik E, Tennenbaum D, Kashan M, Ghanaat M, Casuscelli J, Manley B, Redzematovic A, Mendonca S, Arcila M, Coleman J, Russo P, Hsieh J, Hakimi AA. MP39-02 COMPARATIVE GENOMIC PROFILING OF MATCHED PRIMARY AND METASTATIC TUMORS IN RENAL CELL CARCINOMA Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1176 |
0.363 |
|
| 2017 |
Manley B, Reznik E, Becerra M, Casuscelli J, Tennenbaum D, Ghanaat M, Kashan M, Redzematovic A, Sato Y, Arcila M, Voss M, Feldman D, Russo P, Coleman J, Hsieh J, et al. MP39-01 CHARACTERIZING RECURRENT AND LETHAL SMALL RENAL MASSES IN CLEAR CELL RENAL CELL CARCINOMA USING SOMATIC MUTATIONS Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1175 |
0.368 |
|
| 2016 |
Dong Y, Manley BJ, Becerra MF, Redzematovic A, Casuscelli J, Tennenbaum DM, Reznik E, Han S, Benfante N, Chen YB, Arcila ME, Aras O, Voss MH, Feldman DR, Motzer RJ, ... ... Russo P, et al. Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples. European Urology Focus. PMID 28753786 DOI: 10.1016/J.Euf.2016.08.005 |
0.309 |
|
| 2016 |
Lee BH, Feifer A, Feuerstein MA, Benfante NE, Kou L, Yu C, Kattan MW, Russo P. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma. European Urology Focus. PMID 28753780 DOI: 10.1016/J.Euf.2016.07.006 |
0.362 |
|
| 2016 |
Manley BJ, Zabor EC, Casuscelli J, Tennenbaum DM, Redzematovic A, Becerra MF, Benfante N, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Ogawa S, Arcila ME, Voss MH, ... ... Russo P, et al. Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma. European Urology Focus. PMID 28753773 DOI: 10.1016/J.Euf.2016.06.015 |
0.341 |
|
| 2016 |
Chen YB, Xu J, Skanderup AJ, Dong Y, Brannon AR, Wang L, Won HH, Wang PI, Nanjangud GJ, Jungbluth AA, Li W, Ojeda V, Hakimi AA, Voss MH, Schultz N, ... ... Russo P, et al. Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nature Communications. 7: 13131. PMID 27713405 DOI: 10.1038/Ncomms13131 |
0.31 |
|
| 2016 |
Nguyen DP, Hakimi AA, Vertosick EA, Russo P. Reply to Williamson S.R. What is the malignant potential of clear cell papillary renal cell carcinoma? Urol Oncol 2016; 34: 420. Urologic Oncology. PMID 27697387 DOI: 10.1016/j.urolonc.2016.08.018 |
0.315 |
|
| 2016 |
Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA, McKiernan JM, Libertino JA, Haferkamp A, Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T, ... ... Russo P, et al. Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival. Journal of Surgical Oncology. PMID 27562252 DOI: 10.1002/Jso.24395 |
0.356 |
|
| 2016 |
Russo P. Delayed systemic treatment in metastatic renal-cell carcinoma. The Lancet. Oncology. PMID 27498081 DOI: 10.1016/S1470-2045(16)30247-9 |
0.334 |
|
| 2016 |
Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer FL, Patel SG, Downey RJ, Strong VE, Russo P. Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites. Journal of Surgical Oncology. PMID 27338155 DOI: 10.1002/jso.24327 |
0.314 |
|
| 2016 |
Vilaseca A, Nguyen DP, Vertosick EA, Corradi RB, Musquera M, Pérez M, Fossati N, Sjoberg DD, Farré R, Almendros I, Montserrat JM, Benfante NE, Hakimi AA, Skanderup AJ, Russo P, et al. Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically. World Journal of Urology. PMID 27108420 DOI: 10.1007/s00345-016-1830-6 |
0.314 |
|
| 2016 |
Murray KS, Zabor EC, Spaliviero M, Russo P, Bazzi WM, Musser JE, Ari Hakimi A, Bernstein ML, Dalbagni G, Coleman JA, Furberg H. Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution. World Journal of Urology. PMID 27106493 DOI: 10.1007/s00345-016-1832-4 |
0.322 |
|
| 2016 |
Karlo CA, Kou L, Di Paolo PL, Kattan MW, Motzer RJ, Russo P, Tickoo SK, Akin O, Hricak H. Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. European Journal of Cancer (Oxford, England : 1990). 59: 57-64. PMID 27016623 DOI: 10.1016/J.Ejca.2016.02.012 |
0.311 |
|
| 2016 |
Nguyen DP, Vertosick EA, Corradi RB, Vilaseca A, Benfante NE, Touijer KA, Sjoberg DD, Russo P. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Urologic Oncology. PMID 26947350 DOI: 10.1016/j.urolonc.2016.01.005 |
0.376 |
|
| 2016 |
Hötker AM, Karlo CA, Zheng J, Moskowitz CS, Russo P, Hricak H, Akin O. Clear Cell Renal Cell Carcinoma: Associations Between CT Features and Patient Survival. Ajr. American Journal of Roentgenology. 1-8. PMID 26934514 DOI: 10.2214/Ajr.15.15369 |
0.331 |
|
| 2016 |
Bazzi WM, Tin AL, Sjoberg DD, Bernstein M, Russo P. The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma. The Canadian Journal of Urology. 23: 8151-4. PMID 26892055 |
0.355 |
|
| 2016 |
Mano R, Vertosick EA, Hakimi AA, Sternberg IA, Sjoberg DD, Bernstein M, Dalbagni G, Coleman JA, Russo P. The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm. Urologic Oncology. PMID 26795607 DOI: 10.1016/j.urolonc.2015.12.001 |
0.326 |
|
| 2016 |
Hötker AM, Mazaheri Y, Wibmer A, Zheng J, Moskowitz CS, Tickoo SK, Russo P, Hricak H, Akin O. Use of DWI in the Differentiation of Renal Cortical Tumors. Ajr. American Journal of Roentgenology. 206: 100-5. PMID 26700340 DOI: 10.2214/Ajr.14.13923 |
0.38 |
|
| 2016 |
Schödel J, Grampp S, Maher ER, Moch H, Ratcliffe PJ, Russo P, Mole DR. Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer. European Urology. 69: 646-57. PMID 26298207 DOI: 10.1016/J.Eururo.2015.08.007 |
0.384 |
|
| 2016 |
Casuscelli J, Winer AG, Reznik E, Xu J, Manley B, Chouhan J, Reuter VE, Tickoo S, Russo P, Coleman JA, Hsieh J, Hakimi AA. Single-institutional analysis of patients with clear-cell papillary renal cell carcinoma. Journal of Clinical Oncology. 34: 512-512. DOI: 10.1200/Jco.2016.34.2_Suppl.512 |
0.335 |
|
| 2016 |
Vazquez-Martul Pazos D, Chantada V, Capitanio U, Carballido J, Chromecki T, Ciancio G, Daneshmand S, Evans C, Gontero P, González J, Haferkamp A, Hohenfellner M, Huang W, Koppie T, Linares Espinós E, ... ... Russo P, et al. 524 Preoperative renal artery embolization in renal carcinoma with venous thrombus: Preliminary results of a multicenter study European Urology Supplements. 15: e524-e524a. DOI: 10.1016/S1569-9056(16)60526-2 |
0.349 |
|
| 2016 |
Casuscelli J, Manley B, Redzematovic A, Becerra M, Tennenbaum D, Arcila M, Voss M, Feldman D, Motzer R, Coleman J, Russo P, Hsieh J, Hakimi A. 229 Significance of TERT variants in renal cell carcinoma European Urology Supplements. 15: e229. DOI: 10.1016/S1569-9056(16)60231-2 |
0.375 |
|
| 2016 |
Casuscelli J, Winer AG, Reznik E, Xu J, Manley BJ, Chouhan J, Reuter VE, Tickoo SK, Russo P, Coleman JA, Hsieh JJ, Hakimi AA. MP73-17 SINGLE-INSTITUTIONAL ANALYSIS OF PATIENTS WITH CLEAR-CELL PAPILLARY RENAL CELL CARCINOMA Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1672 |
0.37 |
|
| 2016 |
Casuscelli J, Manley BJ, Mano R, Redzematovic A, Becerra MF, Tennenbaum DM, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Hsieh JJ, Hakimi AA. MP71-14 ANALYSIS OF THE MUTATIONAL LANDSCAPE OF SARCOMATOID CLEAR CELL RENAL CELL CARCINOMA COMPARED TO CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1460 |
0.356 |
|
| 2016 |
Becerra MF, Manley BJ, Casuscelli J, Redzematovic A, Tennenbaum DM, Motzer RJ, Feldman DR, Voss MH, Arcila M, Russo P, Coleman JA, Hsieh JJ, Hakimi AA. MP71-11 GENOMIC LANSCAPE OF CLEAR CELL RENAL CELL CARCINOMA METASTASIS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1457 |
0.339 |
|
| 2016 |
Manley BJ, Casuscelli J, Tennenbaum DM, Becerra MF, Redzematovic A, Arcila ME, Voss MH, Feldman DR, Coleman JA, Russo P, Motzer RJ, Hsieh JJ, Hakimi AA. MP71-10 CLINICAL FEATURES OF RECURRENT SOMATIC MUTATIONS IN CLEAR CELL RENAL CELL CARCINOMA: A LARGE COHORT Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1456 |
0.32 |
|
| 2016 |
Casuscelli J, Manley BJ, Redzematovic A, Becerra MF, Tennenbaum DM, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Russo P, Coleman JA, Hsieh JJ, Hakimi AA. MP71-06 THE IMPACT OF
TERT
PROMOTER REGION MUTATIONS IN RENAL CELL CARCINOMA Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1452 |
0.308 |
|
| 2015 |
Zabor EC, Furberg H, Mashni J, Lee B, Jaimes EA, Russo P. Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26500248 DOI: 10.2215/CJN.04070415 |
0.345 |
|
| 2015 |
Liu NW, Wren JD, Vertosick E, Lee JK, Power NE, Benfante NE, Kimm SY, Bains MS, Sjoberg DD, Russo P, Coleman JA. The Prognostic Impact of a Positive Vascular Margin in pT3 Clear Cell Renal Cell Carcinomas. The Journal of Urology. PMID 26363467 DOI: 10.1016/j.juro.2015.08.099 |
0.328 |
|
| 2015 |
Mashni JW, Assel M, Maschino A, Russo M, Masi B, Bernstein M, Huang WC, Russo P. New Chronic Kidney Disease and Overall Survival after Nephrectomy for Small Renal Cortical Tumors. Urology. PMID 26362947 DOI: 10.1016/j.urology.2015.07.046 |
0.337 |
|
| 2015 |
Bazzi WM, Chen LY, Cordon BH, Mashni J, Sjoberg DD, Bernstein M, Russo P. Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function. International Urology and Nephrology. PMID 26265107 DOI: 10.1007/s11255-015-1066-1 |
0.322 |
|
| 2015 |
Nguyen DP, Vilaseca A, Vertosick EA, Corradi RB, Touijer KA, Benfante NE, Sjoberg DD, Russo P. Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically. World Journal of Urology. PMID 26215750 DOI: 10.1007/s00345-015-1644-y |
0.37 |
|
| 2015 |
Ghoneim TP, Sjoberg DD, Lowrance W, Shariat SF, Savage C, Bernstein M, Russo P. Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics. World Journal of Urology. PMID 25966661 DOI: 10.1007/s00345-015-1581-9 |
0.35 |
|
| 2015 |
Sternberg IA, Katz BF, Baldinger L, Mano R, Paz GE, Bernstein M, Akin O, Russo P, Karlo C. Can renal hemangiomas be diagnosed preoperatively? The Israel Medical Association Journal : Imaj. 17: 157-60. PMID 25946766 |
0.349 |
|
| 2015 |
Mano R, Kent M, Larish Y, Winer AG, Chevinsky MS, Hakimi AA, Sternberg IA, Sjoberg DD, Russo P. Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors. Urology. 85: 1404-10. PMID 25872696 DOI: 10.1016/j.urology.2015.02.032 |
0.358 |
|
| 2015 |
Hakimi AA, Tickoo SK, Jacobsen A, Sarungbam J, Sfakianos JP, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Chen YB, Sankin AI, Mano R, Coleman JA, Russo P, et al. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 845-53. PMID 25676555 DOI: 10.1038/Modpathol.2015.6 |
0.342 |
|
| 2015 |
Mano R, Vertosick E, Sankin AI, Chevinsky MS, Larish Y, Jakubowski CD, Hötker AM, Hakimi AA, Sjoberg DD, Akin O, Russo P. Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma. The Journal of Urology. 193: 776-82. PMID 25241004 DOI: 10.1016/j.juro.2014.09.020 |
0.366 |
|
| 2015 |
Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, ... ... Russo P, et al. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. The Journal of Urology. 193: 436-42. PMID 25063493 DOI: 10.1016/J.Juro.2014.07.087 |
0.323 |
|
| 2015 |
Mano R, Vertosick EA, Hakimi AA, Sternberg IA, Sjoberg DD, Bernstein M, Dalbagni G, Coleman JA, Russo P. The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm Urologic Oncology: Seminars and Original Investigations. DOI: 10.1016/j.urolonc.2015.12.001 |
0.326 |
|
| 2015 |
Murray KS, Zabor EC, Spaliviero M, Russo P, Bazzi WM, Musser JE, Hakimi AA, Bernstein ML, Dalbagni G, Coleman JA, Furberg H. MP50-16 MULTIPLE PRIMARY MALIGNANCIES IN RENAL CORTICAL NEOPLASMS: AN UPDATED EVALUATION Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2927 |
0.304 |
|
| 2015 |
Espinós EL, González J, Martínez-Salamanca JI, Novara G, Bertini R, Carballido J, Chromecki T, Ciancio G, Daneshmand S, Evans C, Gontero P, Haferkamp A, Hohenfellner M, Huang WC, Koppie T, ... ... Russo P, et al. Pi-07 A Transplant-Based Surgical Approach May Improve Postoperative Complications In Cases Of Renal Cell Carcinoma And Tumor Thrombus The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2906 |
0.327 |
|
| 2015 |
Spaliviero M, Power NE, Murray KS, Russo P, Sjoberg DD, Benfante NE, Sun AJ, Bernstein ML, Touijer KA, Dalbagni G, Coleman JA. MP63-08 PHASE 3 RANDOMIZED TRIAL OF INTRAVENOUS MANNITOL VERSUS PLACEBO PRIOR TO RENAL ISCHEMIA DURING PARTIAL NEPHRECTOMY: IMPACT ON RENAL FUNCTIONAL OUTCOMES Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2340 |
0.303 |
|
| 2015 |
Nguyen D, Vertosick E, Beluco Corradi R, Vilaseca A, Sjoberg D, Benfante N, Russo P. MP84-06 HISTOLOGY IMPACTS SURVIVAL OUTCOMES IN CONTEMPORARY PATIENTS UNDERGOING PRIMARILY PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.1973 |
0.373 |
|
| 2015 |
Pak JS, Lascano D, Finkelstein JB, McKiernan JM, DeCastro GJ, Capitanio U, Carballido JA, Chantada V, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Haferkamp A, ... ... Russo P, et al. Mp44-17 The Significance Of Symptomatology: Analysis From The International Renal Cell Carcinoma-Venous Thrombus Consortium (Ircc-Vtc) The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1559 |
0.375 |
|
| 2015 |
Kaffenberger S, Ostrovnaya I, Winer A, Reuter V, Coleman J, Russo P, Hsieh J, Hakimi A. MP44-07 A CRITICAL ANALYSIS AND VALIDATION OF THE RENAL CELL CARCINOMA BIOMARKER LITERATURE USING THE CANCER GENOME ATLAS (TCGA) Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1549 |
0.332 |
|
| 2015 |
Casuscelli J, Lee W, Wang P, Russo P, Coleman JA, Pantuck A, Thompson RH, Reuter VE, Hakimi AA, Hsieh JJ. MP47-14 MUTATION ANALYSIS OF AGGRESSIVE CHROMOPHOBE RENAL CELL CANCER PATIENTS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1534 |
0.306 |
|
| 2015 |
Winer A, Senbabaoglu Y, Kaffenberger S, Coleman J, Russo P, Sander C, Hsieh J, Hakimi A. MP47-13 MUTATIONAL AND PROGNOSTIC ASSOCIATIONS OF IMMUNE CELL SIGNATURES IN CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1533 |
0.301 |
|
| 2015 |
Winer AG, Hoetker A, Vacchio MJ, Zabor EC, Ostravnaya I, Russo P, Hsieh JJ, Akin O, Hakimi AA. MP35-03 RADIOGENOMICS OF CLEAR CELL RENAL CELL CARCINOMA: ASSOCIATIONS BETWEEN IMAGING, MOLECULAR ALTERATIONS AND PATHOLOGIC FEATURES Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1104 |
0.397 |
|
| 2015 |
Kaffenberger S, Ciriello G, Winer A, Voss M, Maranchie J, Tamboli P, Rathmell K, Choueiri T, Motzer R, Coleman J, Russo P, Sander C, Hsieh J, Hakimi A. MP35-01 PROTEOMIC STRATIFICATION OF CLEAR CELL RENAL CELL CARCINOMA UTILIZING THE CANCER GENOME ATLAS (TCGA) WITH EXTERNAL VALIDATION Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1102 |
0.33 |
|
| 2014 |
Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P. Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 8: E675-80. PMID 25408806 DOI: 10.5489/cuaj.1979 |
0.336 |
|
| 2014 |
Russo P, Mano R. Open mini-flank partial nephrectomy: an essential contemporary operation. Korean Journal of Urology. 55: 557-67. PMID 25237456 DOI: 10.4111/kju.2014.55.9.557 |
0.328 |
|
| 2014 |
Sfakianos JP, Hakimi AA, Kim PH, Zabor EC, Mano R, Bernstein M, Karellas M, Russo P. Outcomes in patients undergoing nephrectomy for renal cancer on chronic anticoagulation therapy. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 40: 1700-5. PMID 24813810 DOI: 10.1016/j.ejso.2014.04.010 |
0.345 |
|
| 2014 |
MartÃnez-Salamanca JI, Linares E, González J, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Master VA, ... ... Russo P, et al. Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Current Urology Reports. 15: 404. PMID 24682884 DOI: 10.1007/S11934-014-0404-7 |
0.398 |
|
| 2014 |
Bazzi WM, Huang H, Al-Ahmadie H, Russo P. Clinicopathologic features of renomedullary interstitial cell tumor presenting as the main solid renal mass. Urology. 83: 1104-6. PMID 24642074 DOI: 10.1016/j.urology.2014.01.008 |
0.332 |
|
| 2014 |
Voss MH, Hakimi AA, Pham CG, Brannon AR, Chen YB, Cunha LF, Akin O, Liu H, Takeda S, Scott SN, Socci ND, Viale A, Schultz N, Sander C, Reuter VE, ... Russo P, et al. Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1955-64. PMID 24622468 DOI: 10.1158/1078-0432.CCR-13-2345 |
0.317 |
|
| 2014 |
Song J, Kim E, Mobley J, Vemana G, Tanagho Y, Vetter J, Bhayani S, Russo P, Fugita O, Yang SS, Iwamura M, Figenshau RS. Port site metastasis after surgery for renal cell carcinoma: harbinger of future metastasis. The Journal of Urology. 192: 364-8. PMID 24582771 DOI: 10.1016/j.juro.2014.02.089 |
0.332 |
|
| 2014 |
Russo P. Handling patients with growing small renal masses. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 8: 28-9. PMID 24578739 DOI: 10.5489/cuaj.1899 |
0.321 |
|
| 2014 |
Hakimi AA, Mano R, Ciriello G, Gonen M, Mikkilineni N, Sfakianos JP, Kim PH, Motzer RJ, Russo P, Reuter VE, Hsieh JJ, Ostrovnaya I. Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma. The Journal of Urology. 192: 24-9. PMID 24518768 DOI: 10.1016/J.Juro.2014.01.088 |
0.335 |
|
| 2014 |
Chen YB, Brannon AR, Toubaji A, Dudas ME, Won HH, Al-Ahmadie HA, Fine SW, Gopalan A, Frizzell N, Voss MH, Russo P, Berger MF, Tickoo SK, Reuter VE. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. The American Journal of Surgical Pathology. 38: 627-37. PMID 24441663 DOI: 10.1097/PAS.0000000000000163 |
0.375 |
|
| 2014 |
Hamilton RJ, Morilla D, Cabrera F, Leapman M, Chen LY, Bernstein M, Hakimi AA, Reuter VE, Russo P. The association between statin medication and progression after surgery for localized renal cell carcinoma. The Journal of Urology. 191: 914-9. PMID 24291547 DOI: 10.1016/j.juro.2013.10.141 |
0.361 |
|
| 2014 |
Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, ... ... Russo P, et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. European Urology. 66: 577-83. PMID 23871402 DOI: 10.1016/J.Eururo.2013.06.048 |
0.389 |
|
| 2014 |
Tilki D, Hu B, Nguyen H, Dall'Era M, Thieu W, Bertini R, Carballido J, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang W, ... ... Russo P, et al. 1043 Impact of synchronous metastasis distribution on survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy European Urology Supplements. 13: e1043-e1043a. DOI: 10.1016/S1569-9056(14)61025-3 |
0.369 |
|
| 2014 |
Hakimi AA, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Chen YB, Mano R, Russo P, Ogawa S, Hsieh J, Reuter V, Tickoo S. Mp23-16 Tceb1-Mutated Renal Cell Carcinoma: A Distinct Genomic And Morphologic Subtype The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.884 |
0.313 |
|
| 2014 |
Hakimi AA, Jacobsen A, Mano R, Gonen M, Voss MH, Reuter VE, Rathmell WK, Maranchie JK, Appleman LJ, Tamboli P, Signoretti S, Choueiri TK, Russo P, Motzer RJ, Hsieh JJ. MP23-09 INTEGRATED ANALYSIS OF METASTATIC DISEASE IN CLEAR CELL RENAL CELL CARCINOMA: A COLLABORATIVE TCGA ANALYSIS Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.877 |
0.342 |
|
| 2014 |
Bjurlin M, Elkin E, Atoria C, Russo P, Taneja S, Huang W. MP30-14 DIAGNOSTIC RENAL BIOPSY AND THE TREATMENT OF SMALL KIDNEY CANCERS Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.822 |
0.315 |
|
| 2014 |
Faba OR, Salamanca JIM, Tilki D, Dall'Era MA, Nguyen HG, Roberto B, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Hu B, Gontero P, González J, Haferkamp A, Hohenfellner M, ... ... Russo P, et al. Mp30-13 Impact Of Microscopic Vein Invasion On Cancer-Specific Survival In Patients With Renal Cell Carcinoma And Tumor Thrombus The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.821 |
0.39 |
|
| 2014 |
Kopp R, Stratton K, Glogowski E, Schrader K, Rau-Murthy R, Russo P, Coleman J, Offit K. MP36-06 UTILITY OF PROSPECTIVE PATHOLOGIC EVALUATION TO INFORM CLINICAL GENETIC TESTING FOR HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA Journal of Urology. 191. DOI: 10.1016/j.juro.2014.02.1070 |
0.304 |
|
| 2014 |
Hakimi AA, Tickoo SK, Xu J, Lee C, Mano R, Chen Y, Stirdivant S, Neri B, Wolfert R, Fine SW, Al-Ahmadie H, Gopalan A, Russo P, Reuter VE, Hsieh JJ. MP35-19 SORBITOL AS A NOVEL MECHANISM OF HYPOXIA-INDUCIBLE FACTOR (HIF) PATHWAY ACTIVATION IN CLEAR CELL PAPILLARY RENAL CELL CARCINOMA (CCPRCC) Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1062 |
0.308 |
|
| 2013 |
Lee CH, Cross JR, Li Z, Chen Y, Neri B, Reuter VE, Motzer RJ, Russo P, Hsieh J. Global metabolic profiling of clear cell renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 379. PMID 28136900 DOI: 10.1200/Jco.2013.31.6_Suppl.379 |
0.337 |
|
| 2013 |
Asnis-Alibozek AG, Fine MJ, Russo P, McLaughlin T, Farrelly EM, LaFrance N, Lowrance W. Cost of care for malignant and benign renal masses. The American Journal of Managed Care. 19: 617-24. PMID 24304211 |
0.358 |
|
| 2013 |
Karlo CA, Di Paolo PL, Hricak H, Tickoo SK, Russo P, Akin O. CT of renal cell carcinoma: assessment of collecting system invasion. Ajr. American Journal of Roentgenology. 201: W821-7. PMID 24261389 DOI: 10.2214/AJR.13.10785 |
0.328 |
|
| 2013 |
Karlo CA, Donati OF, Marigliano C, Tickoo SK, Hricak H, Russo P, Akin O. Role of CT in the assessment of muscular venous branch invasion in patients with renal cell carcinoma. Ajr. American Journal of Roentgenology. 201: 847-52. PMID 24059374 DOI: 10.2214/AJR.12.10496 |
0.356 |
|
| 2013 |
Silberstein JL, Sprenkle PC, Su D, Power NE, Tarin TV, Ezell P, Sjoberg DD, Feifer A, Fleisher M, Russo P, Touijer KA. Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model. Bju International. 112: 517-25. PMID 23510358 DOI: 10.1111/bju.12066 |
0.306 |
|
| 2013 |
Karlo CA, Di Paolo PL, Donati OF, Russo P, Tickoo S, Hricak H, Akin O. Renal cell carcinoma: role of MR imaging in the assessment of muscular venous branch invasion. Radiology. 267: 454-9. PMID 23418001 DOI: 10.1148/radiol.13121555 |
0.333 |
|
| 2013 |
Steinhagen E, Moore HG, Lee-Kong SA, Shia J, Eaton A, Markowitz AJ, Russo P, Guillem JG. Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies. Clinical Colorectal Cancer. 12: 23-7. PMID 23026110 DOI: 10.1016/j.clcc.2012.07.004 |
0.337 |
|
| 2013 |
Hakimi AA, Ostrovnaya I, Reva B, Schultz N, Chen Y, Gonen M, Liu H, Takeda S, Tickoo SK, Voss MH, Cheng EH, Reuter VE, Motzer RJ, Russo P, Hsieh JJ. 1068 ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2 Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.657 |
0.311 |
|
| 2013 |
Bazzi W, Cordon BH, Mashni J, Chen L, Sjoberg DD, Coleman J, Touijer KA, Dalbagni G, Russo P. 1794 NON-NEOPLASTIC PARENCHYMAL CHANGES ASSOCIATED WITH RENAL CELL CARCINOMA Journal of Urology. 189. DOI: 10.1016/J.JURO.2013.02.2844 |
0.359 |
|
| 2013 |
Tilki D, Dall'Era MA, Nguyen HG, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz A, ... ... Russo P, et al. 1830 Impact Of Histologic Subtype On Tumor Thrombus Level And Cancer-Specific Survival In Patients With Renal Cell Carcinoma And Vena Cava Thrombus The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2213 |
0.386 |
|
| 2013 |
Hakimi AA, Lee C, Cross JR, Li Z, Chen Y, Neri B, Reuter VE, Motzer R, Russo P, Hsieh JJ. 469 GLOBAL METABOLIC PROFILING OF CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1860 |
0.322 |
|
| 2013 |
Hakimi AA, Jacobsen A, Mikkilineni N, Fiegoli B, Blass S, Grigoryev Y, Viale A, Socci N, Voss MH, Motzer R, Reuter VE, Coleman J, Russo P, Hsieh JJ. 611 MICRORNA AS NOVEL BLOOD-BASED BIOMARKERS IN CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.162 |
0.325 |
|
| 2013 |
Hakimi AA, Reuter VE, Russo P, Hsieh JJ. Reply from authors re: James W.F. Catto, Shahrokh F. Shariat. the changing face of renal cell carcinoma: The impact of systematic genetic sequencing on our understanding of this tumor's biology. Eur Urol 2013;63:855-7: Genetic stratification of clear cell renal carcinomas presenting as small renal masses European Urology. 63: 857-858. DOI: 10.1016/J.Eururo.2012.09.055 |
0.344 |
|
| 2012 |
Russo P, Uzzo RG, Lowrance WT, Asnis-Alibozek A, LaFrance ND, Libertino JA, Pryma DA, Divgi CR. Incidence of benign versus malignant renal tumors in selected studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 357. PMID 27967978 DOI: 10.1200/jco.2012.30.5_suppl.357 |
0.395 |
|
| 2012 |
Power NE, Maschino AC, Savage C, Silberstein JL, Thorner D, Tarin T, Wong A, Touijer KA, Russo P, Coleman JA. Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy. Urology. 79: 821-5. PMID 22469577 DOI: 10.1016/j.urology.2011.11.064 |
0.307 |
|
| 2012 |
Sprenkle PC, Power N, Ghoneim T, Touijer KA, Dalbagni G, Russo P, Coleman JA. Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimeters. European Urology. 61: 593-9. PMID 22154728 DOI: 10.1016/j.eururo.2011.11.040 |
0.382 |
|
| 2012 |
Russo P. Open partial nephrectomy. Personal technique and current outcomes. Archivos Espanoles De Urologia. 64: 571-93. PMID 21965255 |
0.373 |
|
| 2012 |
Russo P. Oncological outcomes of partial nephrectomy for renal carcinoma greater than 4 cm. Current Opinion in Urology. 21: 362-7. PMID 21730851 DOI: 10.1097/MOU.0b013e32834963ee |
0.376 |
|
| 2012 |
Russo P. Renal cell carcinoma : clinical features and management. Methods in Molecular Medicine. 53: 3-33. PMID 21318785 DOI: 10.1385/1-59259-144-2:003 |
0.322 |
|
| 2011 |
Lane BR, Russo P, Uzzo R, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love T, Campbell S. Use of comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys to investigate the role of nonmodifiable factors in determining ultimate renal function. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 321. PMID 27968633 DOI: 10.1200/jco.2011.29.7_suppl.321 |
0.304 |
|
| 2011 |
Gerst S, Hann LE, Li D, Gonen M, Tickoo S, Sohn MJ, Russo P. Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. Ajr. American Journal of Roentgenology. 197: 897-906. PMID 21940577 DOI: 10.2214/AJR.10.6330 |
0.4 |
|
| 2011 |
Russo P. The role of surgery in the management of early-stage renal cancer. Hematology/Oncology Clinics of North America. 25: 737-52. PMID 21763965 DOI: 10.1016/j.hoc.2011.04.009 |
0.358 |
|
| 2011 |
Godoy G, Katz DJ, Adamy A, Jamal JE, Bernstein M, Russo P. Routine drain placement after partial nephrectomy is not always necessary. The Journal of Urology. 186: 411-5. PMID 21683403 DOI: 10.1016/j.juro.2011.03.151 |
0.308 |
|
| 2011 |
Al-Ahmadie HA, Alden D, Fine SW, Gopalan A, Touijer KA, Russo P, Reuter VE, Tickoo SK. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. The American Journal of Surgical Pathology. 35: 949-61. PMID 21677535 DOI: 10.1097/PAS.0b013e31821e25cd |
0.383 |
|
| 2011 |
Rohan SM, Xiao Y, Liang Y, Dudas ME, Al-Ahmadie HA, Fine SW, Gopalan A, Reuter VE, Rosenblum MK, Russo P, Tickoo SK. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 1207-20. PMID 21602815 DOI: 10.1038/modpathol.2011.80 |
0.341 |
|
| 2011 |
Przybycin CG, Cronin AM, Darvishian F, Gopalan A, Al-Ahmadie HA, Fine SW, Chen YB, Bernstein M, Russo P, Reuter VE, Tickoo SK. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution. The American Journal of Surgical Pathology. 35: 962-70. PMID 21602658 DOI: 10.1097/PAS.0b013e31821a455d |
0.323 |
|
| 2011 |
Adamy A, Lowrance WT, Yee DS, Chong KT, Bernstein M, Tickoo SK, Coleman JA, Russo P. Renal oncocytosis: management and clinical outcomes. The Journal of Urology. 185: 795-801. PMID 21239013 DOI: 10.1016/j.juro.2010.10.068 |
0.331 |
|
| 2011 |
Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. The Journal of Urology. 185: 421-7. PMID 21167524 DOI: 10.1016/J.Juro.2010.09.131 |
0.306 |
|
| 2011 |
Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Patil S, Feldman DR, Reuter VE, Russo P, Motzer RJ. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. American Journal of Clinical Oncology. 34: 454-9. PMID 21127411 DOI: 10.1097/Coc.0B013E3181F47Aa4 |
0.358 |
|
| 2011 |
Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, Gupta A, Taylor J, Bernstein M, Adeniran A, Tickoo SK, Reuter VE, Russo P. Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases. The Journal of Urology. 185: 37-42. PMID 21074196 DOI: 10.1016/J.Juro.2010.08.084 |
0.377 |
|
| 2011 |
Russo P. MORBIDITY OF TUMOUR ENUCLEATION FOR RENAL CELL CARCINOMA (RCC): RESULTS OF A SINGLE-CENTRE PROSPECTIVE STUDY Bju International. 109: 378-378. DOI: 10.1111/J.1464-410X.2011.10390.X |
0.374 |
|
| 2011 |
Martinez-Salamanca J, Capitanio U, Huang W, Sorcini A, Bertini R, Bianco F, Carballido J, Ciancio G, Herranz F, Haferkamp A, Koppie T, Martinez-Ballesteros C, Briganti A, Palou J, Pontes E, ... Russo P, et al. 263 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS European Urology Supplements. 10: 103-104. DOI: 10.1016/S1569-9056(11)60261-3 |
0.352 |
|
| 2011 |
Ghoneim T, Lowrance W, Shariat S, Sjoberg D, Savage C, Bernstein M, Russo P. 87 PARTIAL NEPHRECTOMY FOR RENAL TUMORS IN SOLITARY KIDNEYS: AN UPDATE OF THE MEMORIAL SLOAN-KETTERING CANCER EXPERIENCE European Urology Supplements. 10: 54. DOI: 10.1016/S1569-9056(11)60091-2 |
0.311 |
|
| 2011 |
Wu J, Durbin-Johnson B, Martínez-Salamanca JI, Bertini R, Bianco FJ, Carballido JA, Ciancio G, Hernandez C, Herranz F, Haferkamp A, Hohenfellner M, Martinez-Ballesteros C, Montorsi F, Briganti A, Capitanio U, ... ... Russo P, et al. 959 THE IMPACT OF LOCAL AND DISTANT METASTASIS ON SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY WITH TUMOR THROMBECTOMY Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.927 |
0.392 |
|
| 2011 |
Adamy A, Shariat SF, Chong KT, Russo G, Costaras J, Bernstein M, Russo P. 1997 NATURAL HISTORY OF PATIENTS WITH DISEASE RECURRENCE AFTER NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA Journal of Urology. 185. DOI: 10.1016/j.juro.2011.02.2224 |
0.368 |
|
| 2011 |
Martinez-Salamanca JI, Huang W, Capitanio U, Millan I, Bertini R, Bianco F, Rodriguez JC, Ciancio G, Hernandez C, Herranz Amo F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martinez-Ballesteros C, ... ... Russo P, et al. 1760 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS. INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.2088 |
0.394 |
|
| 2011 |
Martinez-Salamanca JI, Capitanio U, Huang W, Millan I, Bertini R, Bianco F, Carballido Rodriguez J, Ciancio G, Hernandez C, Herranz Amo F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martinez-Ballesteros C, ... ... Russo P, et al. 534 CANCER-SPECIFIC SURVIVAL NOMOGRAM FOR RENAL TUMORS WITH VENOUS EXTENSION:INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.1258 |
0.411 |
|
| 2011 |
Martinez-Salamanca JI, Huang W, Millan I, Bertini R, Bianco F, Carballido Rodriguez J, Ciancio G, Hernandez C, Herranz Amo F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martinez-Ballesteros C, Montorsi F, ... ... Russo P, et al. 532 PROGNOSTIC ACCURACY OF THE 2009 UICC/AJCC TNM STAGING SYSTEM FOR RENAL CELL CARCINOMA WITH VENOUS EXTENSION Journal of Urology. 185. DOI: 10.1016/j.juro.2011.02.1256 |
0.351 |
|
| 2010 |
Adamy A, Chong KT, Chade D, Costaras J, Russo G, Kaag MG, Bernstein M, Motzer RJ, Russo P. Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. The Journal of Urology. 185: 433-8. PMID 21167521 DOI: 10.1016/j.juro.2010.09.100 |
0.38 |
|
| 2010 |
Martínez-Salamanca JI, Huang WC, Millán I, Bertini R, Bianco FJ, Carballido JA, Ciancio G, Hernández C, Herranz F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martínez-Ballesteros C, Montorsi F, ... ... Russo P, et al. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. European Urology. 59: 120-7. PMID 20980095 DOI: 10.1016/j.eururo.2010.10.001 |
0.35 |
|
| 2010 |
Adamy A, Favaretto RL, Nogueira L, Savage C, Russo P, Coleman J, Guillonneau B, Touijer K. Recovery of renal function after open and laparoscopic partial nephrectomy. European Urology. 58: 596-601. PMID 20554375 DOI: 10.1016/j.eururo.2010.05.044 |
0.32 |
|
| 2010 |
Russo P. Partial nephrectomy for renal cancer (part II): the impact of renal ischaemia, patient preparation, surgical approaches, management of complications and utilization. Bju International. 105: 1494-507. PMID 20553456 DOI: 10.1111/j.1464-410X.2010.09388.x |
0.329 |
|
| 2010 |
Russo P. Partial nephrectomy for renal cancer: Part I. Bju International. 105: 1206-20. PMID 20500566 DOI: 10.1111/j.1464-410X.2010.09339.x |
0.322 |
|
| 2010 |
Russo P. Multi-modal treatment for metastatic renal cancer: the role of surgery. World Journal of Urology. 28: 295-301. PMID 20364382 DOI: 10.1007/s00345-010-0530-x |
0.315 |
|
| 2010 |
Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States. Cancer. 116: 2316-21. PMID 20225227 DOI: 10.1002/cncr.24965 |
0.331 |
|
| 2010 |
Lowrance WT, Yee DS, Maschino AC, Cronin AM, Bernstein M, Thompson RH, Russo P. Developments in the surgical management of sporadic synchronous bilateral renal tumours Bju International. 105: 1093-1097. PMID 19751262 DOI: 10.1111/j.1464-410X.2009.08844.x |
0.3 |
|
| 2010 |
Chong K, Adamy A, Shariat S, Yee D, Lowrance W, Chade D, Kaag M, Russo P. 438 PREDICTORS OF EARLY OR LATE RECURRENCE AFTER PARTIAL OR RADICAL NEPHRECTOMIES FOR RENAL CELL CARCINOMA European Urology Supplements. 9: 158. DOI: 10.1016/S1569-9056(10)60434-4 |
0.371 |
|
| 2010 |
Russo P. Commentary on Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: An expanded-access trial Urologic Oncology: Seminars and Original Investigations. 28: 231. DOI: 10.1016/j.urolonc.2009.11.019 |
0.311 |
|
| 2010 |
Russo P. Commentary on Surgical resection of renal cell carcinoma after targeted therapy Urologic Oncology: Seminars and Original Investigations. 28: 230-231. DOI: 10.1016/J.UROLONC.2009.11.018 |
0.327 |
|
| 2010 |
Russo P. Commentary on Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage 4N0 renal cell carcinoma) Urologic Oncology: Seminars and Original Investigations. 28: 229-230. DOI: 10.1016/J.UROLONC.2009.11.017 |
0.347 |
|
| 2010 |
Russo P. Commentary on Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma Urologic Oncology: Seminars and Original Investigations. 28: 228-229. DOI: 10.1016/J.UROLONC.2009.11.016 |
0.345 |
|
| 2010 |
Godoy G, Katz D, Adamy A, Bernstein M, Russo P. 831 OMITTING ROUTINE DRAINAGE FOLLOWING OPEN PARTIAL NEPHRECTOMY FOR SMALL CORTICAL RENAL TUMORS Journal of Urology. 183. DOI: 10.1016/J.JURO.2010.02.1532 |
0.333 |
|
| 2010 |
Adamy A, Lima Favaretto R, Chade DC, Nogueira L, Savage C, Russo P, Coleman J, Guillonneau B, Touijer K. 819 RENAL FUNCTION RECOVERY AFTER OPEN AND LAPAROSCOPIC PARTIAL NEPHRECTOMY Journal of Urology. 183. DOI: 10.1016/J.JURO.2010.02.1520 |
0.313 |
|
| 2010 |
Adamy A, Chong KT, Chade DC, Russo G, Costaras J, Bernstein M, Russo P. 1662 CLINICAL CHARACTERISTICS AND SURVIVAL OF PATIENTS THAT RELAPSE AFTER 5 YEARS FROM NEPHRECTOMY FOR RENAL CELL CARCINOMA Journal of Urology. 183. DOI: 10.1016/j.juro.2010.02.1465 |
0.369 |
|
| 2009 |
Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Russo P, Feldman DR, Patil S, Motzer RJ. Treatment outcome and survival for patients (pts) with sarcomatoid-variant metastatic renal cell carcinoma (RCC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e16017. PMID 27962911 DOI: 10.1200/jco.2009.27.15_suppl.e16017 |
0.305 |
|
| 2009 |
Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. Partial Versus Radical Nephrectomy for 4 to 7 cm Renal Cortical Tumors Journal of Urology. 182: 2601-2606. PMID 19836797 DOI: 10.1016/j.juro.2009.08.087 |
0.362 |
|
| 2009 |
Teloken PE, Thompson RH, Tickoo SK, Cronin A, Savage C, Reuter VE, Russo P. Prognostic Impact of Histological Subtype on Surgically Treated Localized Renal Cell Carcinoma Journal of Urology. 182: 2132-2136. PMID 19758615 DOI: 10.1016/j.juro.2009.07.019 |
0.408 |
|
| 2009 |
Becker F, Van Poppel H, Hakenberg OW, Stief C, Gill I, Guazzoni G, Montorsi F, Russo P, Stöckle M. Assessing the impact of ischaemia time during partial nephrectomy. European Urology. 56: 625-34. PMID 19656615 DOI: 10.1016/j.eururo.2009.07.016 |
0.316 |
|
| 2009 |
Coleman JA, Russo P. Hereditary and familial kidney cancer Current Opinion in Urology. 19: 478-485. PMID 19584731 DOI: 10.1097/MOU.0b013e32832f0d40 |
0.325 |
|
| 2009 |
Berglund RK, Bernstein M, Manion MT, Touijer KA, Russo P. Incidental angiomyolipoma resected during renal surgery for an enhancing renal mass. Bju International. 104: 1650-4. PMID 19519761 DOI: 10.1111/j.1464-410X.2009.08677.x |
0.346 |
|
| 2009 |
Thompson RH, Hill JR, Babayev Y, Cronin A, Kaag M, Kundu S, Bernstein M, Coleman J, Dalbagni G, Touijer K, Russo P. Metastatic renal cell carcinoma risk according to tumor size. The Journal of Urology. 182: 41-5. PMID 19450840 DOI: 10.1016/j.juro.2009.02.128 |
0.371 |
|
| 2009 |
Russo P. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. European Urology. 57: 472-3. PMID 19359086 DOI: 10.1016/j.eururo.2009.03.050 |
0.337 |
|
| 2009 |
Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, Nogueira L, Reuter VE, Russo P. Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma Cases Journal of Urology. 181: 2033-2036. PMID 19286217 DOI: 10.1016/j.juro.2009.01.027 |
0.334 |
|
| 2009 |
Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? The Journal of Urology. 181: 55-61; discussion 61. PMID 19012918 DOI: 10.1016/J.Juro.2008.09.017 |
0.302 |
|
| 2009 |
Russo P, Huang W. The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. The Urologic Clinics of North America. 35: 635-43; vii. PMID 18992617 DOI: 10.1016/j.ucl.2008.07.008 |
0.34 |
|
| 2009 |
Ariaratnam N, Riedl C, Tickoo S, Russo P, Rademaker J, Zhang J. Renal oncocytosis: imaging considerations. Abdominal Imaging. 34: 261-4. PMID 18297334 DOI: 10.1007/s00261-008-9375-9 |
0.306 |
|
| 2009 |
Teloken PE, Thompson RH, Tickoo SK, Cronin AM, Savage CJ, Reuter VE, Russo P. CLEAR CELL HISTOLOGY REPRESENTS WORSE PROGNOSIS IN PATIENTS UNDERGOING SURGICAL TREATMENT FOR RENAL CELL CARCINOMA Journal of Urology. 181: 355-356. DOI: 10.1016/S0022-5347(09)61008-9 |
0.373 |
|
| 2009 |
Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. SURVIVAL FOLLOWING PARTIAL VERSUS RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS 4-7CM Journal of Urology. 181: 320-321. DOI: 10.1016/S0022-5347(09)60912-5 |
0.316 |
|
| 2009 |
Thompson RH, Hill JR, Babayev Y, Cronin AM, Kaag M, Kundu SD, Bernstein M, Coleman JA, Dalbagni G, Touijer KA, Russo P. RISK OF METASTATIC RENAL CELL CARCINOMA ACCORDING TO TUMOR SIZE Journal of Urology. 181: 212-213. DOI: 10.1016/S0022-5347(09)60610-8 |
0.361 |
|
| 2009 |
Russo P. The screening for occult renal disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small renal masses Urologic Oncology: Seminars and Original Investigations. 27: 105. DOI: 10.1016/j.urolonc.2008.11.011 |
0.303 |
|
| 2009 |
Russo P. Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma—does it affect survival? Urologic Oncology: Seminars and Original Investigations. 27: 104. DOI: 10.1016/j.urolonc.2008.11.010 |
0.336 |
|
| 2009 |
Russo P. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma Urologic Oncology: Seminars and Original Investigations. 27: 103-104. DOI: 10.1016/J.UROLONC.2008.11.009 |
0.35 |
|
| 2008 |
Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Blute ML, Russo P, Kwon ED, Allison JP. Evaluation of soluble B7x as a serum marker in patients with clear cell renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5052. PMID 27948878 DOI: 10.1200/Jco.2008.26.15_Suppl.5052 |
0.362 |
|
| 2008 |
Jang TL, Pettus JA, Huang WC, Eggener SE, O'Brien MF, Karellas ME, Kagiwada MA, Russo P. Survival rates after resection for localized kidney cancer: 1989 - 2004. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5115. PMID 27948049 DOI: 10.1200/jco.2008.26.15_suppl.5115 |
0.329 |
|
| 2008 |
Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada M, Russo P. Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clinic Proceedings. 83: 1101-6. PMID 18828969 DOI: 10.4065/83.10.1101 |
0.375 |
|
| 2008 |
Karellas ME, Jang TL, Kagiwada MA, Kinnaman MD, Jarnagin WR, Russo P. Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection. Bju International. 103: 160-4. PMID 18782305 DOI: 10.1111/j.1464-410X.2008.08025.x |
0.347 |
|
| 2008 |
Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, Touijer K. Renal Cell Carcinoma in Young and Old Patients-Is There a Difference? Journal of Urology. 180: 1262-1266. PMID 18707708 DOI: 10.1016/j.juro.2008.06.037 |
0.381 |
|
| 2008 |
Russo P. Editorial comment on: Prognosis value of renal vein and inferior vena cava involvement in renal cell carcinoma. European Urology. 55: 459. PMID 18692952 DOI: 10.1016/j.eururo.2008.07.054 |
0.384 |
|
| 2008 |
Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Cheville JC, Blute ML, Russo P, Kwon ED, Allison JP. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Research. 68: 6054-8. PMID 18676826 DOI: 10.1158/0008-5472.Can-08-0869 |
0.336 |
|
| 2008 |
Russo P. Should elective partial nephrectomy be performed for renal cell carcinoma >4 cm in size? Nature Clinical Practice. Urology. 5: 482-3. PMID 18648330 DOI: 10.1038/ncpuro1177 |
0.417 |
|
| 2008 |
Eggener SE, Yossepowitch O, Kundu S, Motzer RJ, Russo P. Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma. The Journal of Urology. 180: 873-8; discussion 87. PMID 18635225 DOI: 10.1016/j.juro.2008.05.006 |
0.368 |
|
| 2008 |
Feldman DR, Kondagunta GV, Schwartz L, Patil S, Ishill N, DeLuca J, Russo P, Motzer RJ. Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma. Clinical Genitourinary Cancer. 6: 25-30. PMID 18501079 DOI: 10.3816/CGC.2008.n.004 |
0.31 |
|
| 2008 |
Masterson TA, Russo P. A case of port-site recurrence and locoregional metastasis after laparoscopic partial nephrectomy. Nature Clinical Practice. Urology. 5: 345-9. PMID 18490937 DOI: 10.1038/ncpuro1127 |
0.354 |
|
| 2008 |
Russo P, Jang TL, Pettus JA, Huang WC, Eggener SE, O'Brien MF, Karellas ME, Karanikolas NT, Kagiwada MA. Survival rates after resection for localized kidney cancer: 1989 to 2004. Cancer. 113: 84-96. PMID 18470927 DOI: 10.1002/cncr.23520 |
0.337 |
|
| 2008 |
Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. The Journal of Urology. 179: 2146-51; discussion . PMID 18423735 DOI: 10.1016/j.juro.2008.01.101 |
0.301 |
|
| 2008 |
Russo P. Editorial comment on: preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance. European Urology. 54: 149-50. PMID 18407405 DOI: 10.1016/j.eururo.2008.03.059 |
0.322 |
|
| 2008 |
Russo P. Functional preservation in patients with renal cortical tumors: the rationale for partial nephrectomy. Current Urology Reports. 9: 15-21. PMID 18366969 DOI: 10.1007/S11934-008-0005-4 |
0.34 |
|
| 2008 |
Al-Ahmadie HA, Olgac S, Gregor PD, Tickoo SK, Fine SW, Kondagunta GV, Scher HI, Morris MJ, Russo P, Motzer RJ, Reuter VE. Expression of prostate-specific membrane antigen in renal cortical tumors. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 727-32. PMID 18344976 DOI: 10.1038/modpathol.2008.42 |
0.38 |
|
| 2008 |
O'Brien MF, Russo P, Motzer RJ. Sunitinib therapy in renal cell carcinoma Bju International. 101: 1339-1342. PMID 18284408 DOI: 10.1111/j.1464-410X.2008.07506.x |
0.346 |
|
| 2008 |
Huang WC, Russo P. Rational approach to the treatment of a patient with a small renal cortical tumor. Nature Clinical Practice. Urology. 4: 688-91. PMID 18059349 DOI: 10.1038/ncpuro0970 |
0.322 |
|
| 2008 |
Huang WC, Elkin EB, Russo P. DISPARITIES IN UTILIZATION OF PARTIAL NEPHRECTOMY IN PATIENTS WITH SMALL RENAL TUMORS Journal of Urology. 179: 417-417. DOI: 10.1016/S0022-5347(08)61222-7 |
0.359 |
|
| 2008 |
Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada MA, Russo P. DECLININING BASELINE GFR IMPACTS SURVIVAL IN PATIENTS UNDERGOING PARTIAL OR RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS Journal of Urology. 179: 378-378. DOI: 10.1016/S0022-5347(08)61106-4 |
0.343 |
|
| 2008 |
Russo P. Prognostic significance of erythropoietin expression in human renal cell carcinoma Urologic Oncology: Seminars and Original Investigations. 26: 106. DOI: 10.1016/J.UROLONC.2007.11.013 |
0.341 |
|
| 2008 |
Russo P. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: The M.D. Anderson Cancer Center experience Urologic Oncology: Seminars and Original Investigations. 26: 103-104. DOI: 10.1016/j.urolonc.2007.11.010 |
0.315 |
|
| 2008 |
Russo P. Renal cell carcinoma clinically involving adjacent organs: Experience with aggressive surgical management Urologic Oncology: Seminars and Original Investigations. 26: 102-103. DOI: 10.1016/j.urolonc.2007.11.009 |
0.318 |
|
| 2007 |
Russo P. Is laparoscopic partial nephrectomy as effective as open partial nephrectomy in patients with renal cell carcinoma? Nature Clinical Practice. Urology. 5: 12-3. PMID 17909555 DOI: 10.1038/NCPURO0938 |
0.396 |
|
| 2007 |
Huang WC, Kagiwada MA, Russo P. Surgery insight: advances in techniques for open partial nephrectomy. Nature Clinical Practice. Urology. 4: 444-50. PMID 17673915 DOI: 10.1038/ncpuro0855 |
0.313 |
|
| 2007 |
Russo P, Synder M, Vickers A, Kondagunta V, Motzer R. Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. Thescientificworldjournal. 7: 768-78. PMID 17619759 DOI: 10.1100/tsw.2007.145 |
0.347 |
|
| 2007 |
Pettus JA, Sharp DS, Yossepowitch O, Schacter LR, Ferrandino MN, Snyder ME, Bach AM, Russo P. Tumor location does not affect long-term renal function after partial nephrectomy. Urology. 69: 1059-63. PMID 17572186 DOI: 10.1016/j.urology.2007.02.058 |
0.312 |
|
| 2007 |
Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gönen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. The Lancet. Oncology. 8: 304-10. PMID 17395103 DOI: 10.1016/S1470-2045(07)70044-X |
0.365 |
|
| 2007 |
Tickoo SK, Alden D, Olgac S, Fine SW, Russo P, Kondagunta GV, Motzer RJ, Reuter VE. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma. The Journal of Urology. 177: 1258-63. PMID 17382701 DOI: 10.1016/j.juro.2006.11.100 |
0.375 |
|
| 2007 |
Russo P. For small renal tumors, kidney sparing surgery provides local tumor control and prevents chronic kidney disease. Onkologie. 30: 92-3. PMID 17341893 DOI: 10.1159/000099027 |
0.307 |
|
| 2007 |
Russo P. Partial nephrectomy achieves local tumor control and prevents chronic kidney disease. Expert Review of Anticancer Therapy. 6: 1745-51. PMID 17181488 DOI: 10.1586/14737140.6.12.1745 |
0.354 |
|
| 2007 |
Kwon EO, Carver BS, Snyder ME, Russo P. Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. Bju International. 99: 286-9. PMID 17155985 DOI: 10.1111/j.1464-410X.2006.06623.x |
0.321 |
|
| 2007 |
Karanikolas NT, Jang TL, Eggener SE, Karellas M, Tickoo SK, Russo P. 1301: Clinical, Pathologic and Survival Characteristics of Late Relapse Renal Cell Carcinoma Journal of Urology. 177: 428-428. DOI: 10.1016/s0022-5347(18)31515-5 |
0.36 |
|
| 2007 |
Hill JR, Kagiwada MA, Huang WC, Coleman JA, Russo P. 906: Minimal Metastatic Disease Encountered in Resected Malignant Renal Cortical Tumors <3CM Journal of Urology. 177: 300-301. DOI: 10.1016/S0022-5347(18)31134-0 |
0.318 |
|
| 2007 |
Martinez-Salamanca JI, Aragona MS, Bianco FJ, Canes D, Carballido J, Ciancio G, Hernandez C, Herranz F, Huang WC, Lopez I, Ballesteros CM, Palau J, Pontes JE, Romero J, Rosales A, ... Russo P, et al. 632: Prognostic Significance of Venous Thrombus in Renal Cell Carcinoma: A Multiinstitutional Study Journal of Urology. 177: 212-212. DOI: 10.1016/S0022-5347(18)30872-3 |
0.384 |
|
| 2007 |
Jang TL, Huang WC, Eggener SE, O'Brien MF, Karanikolas NT, Pettus JA, Kagiwada MA, Russo P. 578: Impact of Stage Migration on Disease Progression Trends in Patients after Nephrectomy for Localized Renal Cell Carcinoma Journal of Urology. 177: 193-193. DOI: 10.1016/S0022-5347(18)30818-8 |
0.356 |
|
| 2007 |
Huang WC, Elkin EB, Jang TL, Russo P. 493: Radical Nephrectomy is Associated with Increased Mortality in Patients with Small Renal Tumors Journal of Urology. 177: 164-165. DOI: 10.1016/S0022-5347(18)30733-X |
0.322 |
|
| 2006 |
Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P. Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. The Journal of Urology. 176: 2391-5; discussion 2. PMID 17085108 DOI: 10.1016/J.Juro.2006.08.013 |
0.35 |
|
| 2006 |
Ronnen EA, Kondagunta GV, Ishill N, Spodek L, Russo P, Reuter V, Bacik J, Motzer RJ. Treatment outcome for metastatic papillary renal cell carcinoma patients. Cancer. 107: 2617-21. PMID 17083126 DOI: 10.1002/cncr.22340 |
0.356 |
|
| 2006 |
Ronnen EA, Kondagunta GV, Ginsberg MS, Russo P, Motzer RJ. Long-term response with sunitinib for metastatic renal cell carcinoma. Urology. 68: 672.e19-20. PMID 16979716 DOI: 10.1016/J.UROLOGY.2006.03.042 |
0.329 |
|
| 2006 |
Yossepowitch O, Eggener SE, Serio A, Huang WC, Snyder ME, Vickers AJ, Russo P. Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function. The Journal of Urology. 176: 1339-43; discussion . PMID 16952626 DOI: 10.1016/j.juro.2006.06.046 |
0.312 |
|
| 2006 |
Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. The Lancet. Oncology. 7: 735-40. PMID 16945768 DOI: 10.1016/S1470-2045(06)70803-8 |
0.302 |
|
| 2006 |
Sorbellini M, Kattan MW, Snyder ME, Hakimi AA, Sarasohn DM, Russo P. Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. The Journal of Urology. 176: 472-6; discussion 47. PMID 16813869 DOI: 10.1016/J.Juro.2006.03.090 |
0.345 |
|
| 2006 |
Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3101-6. PMID 16809736 DOI: 10.1200/JCO.2005.04.8280 |
0.367 |
|
| 2006 |
Dash A, Vickers AJ, Schachter LR, Bach AM, Snyder ME, Russo P. Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. Bju International. 97: 939-45. PMID 16643474 DOI: 10.1111/j.1464-410X.2006.06060.x |
0.365 |
|
| 2006 |
Bruno JJ, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival. Bju International. 97: 933-8. PMID 16643473 DOI: 10.1111/j.1464-410X.2006.06076.x |
0.354 |
|
| 2006 |
Russo P. Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy. Nature Clinical Practice. Urology. 1: 26-30. PMID 16474463 DOI: 10.1038/ncpuro0029 |
0.403 |
|
| 2006 |
Kwon EO, Carver BS, Snyder ME, Russo P. 1125: Impact of Positive Surgical Margins in Patients Undergoing Partial Nephrectomy for Renal Cortical Tumors Journal of Urology. 175: 362-362. DOI: 10.1016/S0022-5347(18)33350-0 |
0.332 |
|
| 2006 |
Bruno JJ, Snyder ME, Motzer RJ, Russo P. 1124: Renal Cell Carcinoma Local Recurrences: Impact of Surgical Treatment and Concomitant Metastasis on Survival Journal of Urology. 175: 361-362. DOI: 10.1016/s0022-5347(18)33349-4 |
0.34 |
|
| 2006 |
Kwon EO, Snyder ME, Russo P, Rabbani F. 1097: Metachronous Contralateral Renal Cell Carcinoma: Influence of Race and Tumor Histology Journal of Urology. 175: 353-353. DOI: 10.1016/s0022-5347(18)33322-6 |
0.388 |
|
| 2006 |
Huang WC, Snyder ME, Raj GV, Serio A, Vickers AJ, Russo P. 734: Patients Undergoing Radical Nephrectomy for Small Renal Cortical Tumors are at Increased Risk for Developing Chronic Renal Insufficiency Journal of Urology. 175: 238-239. DOI: 10.1016/S0022-5347(18)32970-7 |
0.356 |
|
| 2006 |
Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. 719: Renal Cell Carcinoma Recurrence Following Nephrectomy for Localized Disease: Predicting Survival from Time of Recurrence Journal of Urology. 175: 233-233. DOI: 10.1016/S0022-5347(18)32955-0 |
0.32 |
|
| 2006 |
Russo P. Pediatric renal cell carcinoma: Single institution 25 year case series and initial experience with partial nephrectomy Urologic Oncology: Seminars and Original Investigations. 24: 561. DOI: 10.1016/J.UROLONC.2006.08.007 |
0.34 |
|
| 2006 |
Russo P. Translocation carcinomas of the kidney after chemotherapy in childhood Urologic Oncology: Seminars and Original Investigations. 24: 558-559. DOI: 10.1016/J.UROLONC.2006.08.004 |
0.304 |
|
| 2005 |
Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, McKiernan J, Russo P. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. The Journal of Urology. 173: 48-51. PMID 15592023 DOI: 10.1097/01.Ju.0000148261.19532.2C |
0.399 |
|
| 2005 |
Dash A, Snyder ME, Bruno J, Russo P. 49: Elective Partial versus Elective Radical Nephrectomy for Clear Cell Renal Cell Carcinoma 4-7 Cm in Size Journal of Urology. 173: 14-14. DOI: 10.1016/s0022-5347(18)34314-3 |
0.348 |
|
| 2004 |
Saranchuk JW, Touijer AK, Hakimian P, Snyder ME, Russo P. Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. Bju International. 94: 1323-8. PMID 15610114 DOI: 10.1111/j.1464-410X.2004.05165.x |
0.311 |
|
| 2004 |
Kondagunta GV, Drucker B, Schwartz L, Bacik J, Marion S, Russo P, Mazumdar M, Motzer RJ. Phase II trial of bortezomib for patients with advanced renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3720-5. PMID 15365068 DOI: 10.1200/JCO.2004.10.155 |
0.372 |
|
| 2004 |
Diblasio CJ, Snyder ME, Kattan MW, Russo P. Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy. The Journal of Urology. 171: 1062-5. PMID 14767271 DOI: 10.1097/01.Ju.0000109961.69936.8E |
0.313 |
|
| 2004 |
Rabbani F, Hakimian P, Reuter VE, Simmons R, Russo P. Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology. The Journal of Urology. 171: 1057-61. PMID 14767270 DOI: 10.1097/01.JU.0000112885.66352.E2 |
0.414 |
|
| 2004 |
Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 454-63. PMID 14752067 DOI: 10.1200/JCO.2004.06.132 |
0.359 |
|
| 2004 |
Beck SD, Patel MI, Snyder ME, Kattan MW, Motzer RJ, Reuter VE, Russo P. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Annals of Surgical Oncology. 11: 71-7. PMID 14699037 DOI: 10.1007/Bf02524349 |
0.412 |
|
| 2004 |
Russo P, Snyder ME, Rabbani F, Kattan MW, Motzer R, Reuter V. Changing demographics and the contemporary surgical management of renal cortical tumors Journal of Clinical Oncology. 22: 4637-4637. DOI: 10.1200/Jco.2004.22.90140.4637 |
0.318 |
|
| 2003 |
Russo P. Seeking the solution to the problem of metastatic renal carcinoma. Cancer. 97: 2941-4. PMID 12784326 DOI: 10.1002/cncr.11439 |
0.302 |
|
| 2003 |
Patel MI, Simmons R, Kattan MW, Motzer RJ, Reuter VE, Russo P. Long-term follow-up of bilateral sporadic renal tumors Urology. 61: 921-925. PMID 12736005 DOI: 10.1016/S0090-4295(02)02578-5 |
0.333 |
|
| 2003 |
Gilbert SM, Russo P, Benson MC, Olsson CA, McKiernan JM. The evolving role of partial nephrectomy in the management of renal cell carcinoma Current Oncology Reports. 5: 239-244. PMID 12667422 DOI: 10.1007/S11912-003-0116-5 |
0.418 |
|
| 2002 |
McKiernan J, Yossepowitch O, Kattan MW, Simmons R, Motzer RJ, Reuter VE, Russo P. Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology. 60: 1003-1009. PMID 12475658 DOI: 10.1016/S0090-4295(02)01967-2 |
0.414 |
|
| 2002 |
Lee CT, Katz J, Fearn PA, Russo P. Mode of presentation of renal cell carcinoma provides prognostic information. Urologic Oncology. 7: 135-40. PMID 12474528 DOI: 10.1016/S1078-1439(01)00185-5 |
0.37 |
|
| 2002 |
Russo P. Re: laparoscopic radical nephrectomy: cancer control for renal cell carcinoma. The Journal of Urology. 168: 1109; author reply 1. PMID 12187242 DOI: 10.1097/01.ju.0000024781.26798.47 |
0.359 |
|
| 2002 |
Russo P, Goetzl M, Simmons R, Katz J, Motzer R, Reuter V. Partial nephrectomy: the rationale for expanding the indications. Annals of Surgical Oncology. 9: 680-7. PMID 12167583 DOI: 10.1007/BF02574485 |
0.351 |
|
| 2002 |
Russo P. Localized renal cell carcinoma. Current Treatment Options in Oncology. 2: 447-55. PMID 12057108 DOI: 10.1007/S11864-001-0050-4 |
0.39 |
|
| 2002 |
McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 59: 816-20. PMID 12031359 DOI: 10.1016/S0090-4295(02)01501-7 |
0.354 |
|
| 2002 |
Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2376-81. PMID 11981011 DOI: 10.1200/JCO.2002.11.123 |
0.375 |
|
| 2002 |
Rabbani F, Herr HW, Almahmeed T, Russo P. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2370-5. PMID 11981010 DOI: 10.1200/JCO.2002.08.099 |
0.373 |
|
| 2002 |
Motzer RJ, Berg W, Ginsberg M, Russo P, Vuky J, Yu R, Bacik J, Mazumdar M. Phase II trial of thalidomide for patients with advanced renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 302-6. PMID 11773183 |
0.37 |
|
| 2002 |
Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 289-96. PMID 11773181 DOI: 10.1200/JCO.2002.20.1.289 |
0.311 |
|
| 2002 |
Russo P. RE: LAPAROSCOPIC RADICAL NEPHRECTOMY: CANCER CONTROL FOR RENAL CELL CARCINOMA Journal of Urology. 168: 1109-1109. DOI: 10.1016/S0022-5347(05)64595-8 |
0.359 |
|
| 2001 |
Lee CT, Hilton S, Russo P. Renal mass within a horseshoe kidney: preoperative evaluation with three-dimensional helical computed tomography. Urology. 57: 168. PMID 11164171 DOI: 10.1016/S0090-4295(00)00857-8 |
0.309 |
|
| 2001 |
KATTAN MW, REUTER V, MOTZER RJ, KATZ J, RUSSO P. A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA Journal of Urology. 166: 63-67. DOI: 10.1016/S0022-5347(05)66077-6 |
0.364 |
|
| 2000 |
Rabbani F, Reuter VE, Katz J, Russo P. Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology. 56: 399-403. PMID 10962302 DOI: 10.1016/S0090-4295(00)00682-8 |
0.361 |
|
| 2000 |
Motzer RJ, Mazumdar M, Bacik J, Russo P, Berg WJ, Metz EM. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 1928-35. PMID 10784634 DOI: 10.1200/JCO.2000.18.9.1928 |
0.343 |
|
| 2000 |
MOTZER RJ, RUSSO P. SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA Journal of Urology. 163: 408-417. DOI: 10.1016/S0022-5347(05)67889-5 |
0.322 |
|
| 1999 |
Rabbani F, Russo P. Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma. Urology. 54: 28-33. PMID 10414722 DOI: 10.1016/S0090-4295(99)00066-7 |
0.348 |
|
| 1998 |
Grimaldi G, Reuter V, Russo P. Bilateral non-familial renal cell carcinoma. Annals of Surgical Oncology. 5: 548-52. PMID 9754765 DOI: 10.1007/BF02303649 |
0.38 |
|
| 1998 |
Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 2261-6. PMID 9626229 DOI: 10.1200/JCO.1998.16.6.2261 |
0.375 |
|
| 1998 |
RABBANI F, GRIMALDI G, RUSSO P. MULTIPLE PRIMARY MALIGNANCIES IN RENAL CELL CARCINOMA Journal of Urology. 160: 1255-1259. DOI: 10.1016/S0022-5347(01)62510-2 |
0.376 |
|
| 1997 |
Silver DA, Morash C, Brenner P, Campbell S, Russo P. Pathologic findings at the time of nephrectomy for renal mass. Annals of Surgical Oncology. 4: 570-4. PMID 9367023 DOI: 10.1007/BF02305538 |
0.357 |
|
| 1996 |
Wroński M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology. 47: 187-93. PMID 8607231 DOI: 10.1016/S0090-4295(99)80413-0 |
0.37 |
|
| 1988 |
Gilbert BR, Russo P, Zirinsky K, Kazam E, Fair WR, Vaughan ED. Intraoperative sonography: application in renal cell carcinoma. The Journal of Urology. 139: 582-4. PMID 3278141 DOI: 10.1016/S0022-5347(17)42534-1 |
0.403 |
|
| Show low-probability matches. |